MCID: HMF004
MIFTS: 38

Hemifacial Spasm

Categories: Genetic diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Hemifacial Spasm

MalaCards integrated aliases for Hemifacial Spasm:

Name: Hemifacial Spasm 53 29

Classifications:



Summaries for Hemifacial Spasm

NINDS : 53 Hemifacial spasm is a neuromuscular disorder characterized by frequent involuntary contractions (spasms) of the muscles on one side (hemi-) of the face (facial). The disorder occurs in both men and women, although it more frequently affects middle-aged or elderly women. It is much more common in the Asian population.  The first symptom is usually an intermittent twitching of the eyelid muscle that can lead to forced closure of the eye. The spasm may then gradually spread to involve the muscles of the lower face, which may cause the mouth to be pulled to one side. Eventually the spasms involve all of the muscles on one side of the face almost continuously. The condition may be caused by a facial nerve injury, or a tumor, or it may have no apparent cause. Rarely, doctors see individuals with spasm on both sides of the face.  Most often hemifacial spasm is caused by a blood vessel pressing on the facial nerve at the place where it exits the brainstem.

MalaCards based summary : Hemifacial Spasm is related to moyamoya disease 1 and sleep apnea. An important gene associated with Hemifacial Spasm is FLT4 (Fms Related Receptor Tyrosine Kinase 4), and among its related pathways/superpathways are PI3K-Akt signaling pathway and VEGF Pathway (Qiagen). The drugs Pharmaceutical Solutions and Acetylcholine have been mentioned in the context of this disorder. Affiliated tissues include eye, brain and bone, and related phenotype is liver/biliary system.

Wikipedia : 74 Hemifacial spasm (HFS) is a rare neuromuscular disease characterized by irregular, involuntary muscle... more...

Related Diseases for Hemifacial Spasm

Diseases in the Hemifacial Spasm family:

Hemifacial Spasm, Familial

Diseases related to Hemifacial Spasm via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 281, show less)
# Related Disease Score Top Affiliating Genes
1 moyamoya disease 1 29.9 VEGFA MTHFR
2 sleep apnea 29.7 VEGFA NOS3
3 atherosclerosis susceptibility 29.3 VEGFA NOS3 MTHFR
4 hemifacial spasm, familial 13.0
5 blepharospasm 11.0
6 trigeminal neuralgia 11.0
7 facial paralysis 10.9
8 facial spasm 10.8
9 dystonia 10.8
10 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 10.8
11 ptosis 10.7
12 movement disease 10.7
13 pica disease 10.7
14 branchiootic syndrome 1 10.6
15 blepharospasm, benign essential 10.6
16 cervical dystonia 10.6
17 bell's palsy 10.6
18 meningioma, radiation-induced 10.6
19 meningioma, familial 10.6
20 spinal meningioma 10.6
21 secretory meningioma 10.6
22 lymphoplasmacyte-rich meningioma 10.6
23 glossopharyngeal neuralgia 10.6
24 focal dystonia 10.5
25 torticollis 10.5
26 sensorineural hearing loss 10.5
27 arteriovenous malformation 10.5
28 seizures, benign familial neonatal, 1 10.5
29 neurilemmoma 10.5
30 rare surgical neurologic disease 10.5
31 arthrogryposis, mental retardation, and seizures 10.4
32 lipomatosis, multiple 10.4
33 oromandibular dystonia 10.4
34 pleomorphic lipoma 10.4
35 tic disorder 10.4
36 cerebrospinal fluid leak 10.4
37 chiari malformation 10.4
38 aneurysm 10.4
39 acoustic neuroma 10.4
40 47,xyy 10.4
41 myoclonus 10.4
42 epidermoid cysts 10.3
43 lymphatic malformation 5 10.3
44 arachnoid cysts, intracranial 10.3
45 mammary paget's disease 10.3
46 cranial nerve palsy 10.3
47 headache 10.3
48 migraine with or without aura 1 10.3
49 hydrocephalus 10.3
50 lagophthalmos 10.3
51 dysphagia 10.3
52 tremor 10.3
53 astigmatism 10.3
54 cholesteatoma of middle ear 10.3
55 entropion 10.3
56 astrocytoma 10.3
57 intracranial hypertension 10.3
58 multiple sclerosis 10.2
59 strabismus 10.2
60 chiari malformation type ii 10.2
61 yemenite deaf-blind hypopigmentation syndrome 10.2
62 intracranial aneurysm 10.2
63 arteriosclerosis 10.2
64 cerebellopontine angle meningioma 10.2
65 neuropathy 10.2
66 mechanical strabismus 10.2
67 pathologic nystagmus 10.2
68 48,xyyy 10.2
69 glioma 10.2
70 glial tumor 10.2
71 lymphangiosarcoma 10.1 VEGFA FLT4
72 angiosarcoma 10.1 VEGFA FLT4
73 stork bite 10.1 VEGFA FLT4
74 capillary disease 10.1 VEGFA FLT4
75 capillary hemangioma 10.1 VEGFA FLT4
76 hydrocele 10.1 VEGFA FLT4
77 arteriovenous malformations of the brain 10.1
78 gilles de la tourette syndrome 10.1
79 neurofibromatosis, type iv, of riccardi 10.1
80 obsessive-compulsive disorder 10.1
81 syringomyelia, noncommunicating isolated 10.1
82 ataxia and polyneuropathy, adult-onset 10.1
83 anxiety 10.1
84 chorea, childhood-onset, with psychomotor retardation 10.1
85 mastoiditis 10.1
86 cysticercosis 10.1
87 lyme disease 10.1
88 visual epilepsy 10.1
89 spastic entropion 10.1
90 choreatic disease 10.1
91 neuroma 10.1
92 gangliocytoma 10.1
93 bruxism 10.1
94 syringomyelia 10.1
95 pleomorphic adenoma 10.1
96 ganglioglioma 10.1
97 paget's disease of bone 10.1
98 adenoma 10.1
99 juvenile pilocytic astrocytoma 10.1
100 chickenpox 10.1
101 cluster headache 10.1
102 spasmodic dysphonia 10.1
103 depression 10.1
104 seizure disorder 10.1
105 syncope 10.1
106 lymphangioma 10.1 VEGFA FLT4
107 cardiovascular cancer 10.1 VEGFA FLT4
108 vascular cancer 10.1 VEGFA FLT4
109 branch retinal artery occlusion 10.1 VEGFA MTHFR
110 retinal artery occlusion 10.1 VEGFA MTHFR
111 retinal vascular occlusion 10.1 VEGFA MTHFR
112 cardiovascular organ benign neoplasm 10.1 VEGFA FLT4
113 central retinal vein occlusion 10.1 VEGFA MTHFR
114 retinal vein occlusion 10.1 VEGFA MTHFR
115 pulmonary artery disease 10.0 VEGFA MTHFR
116 filariasis 10.0 VEGFA FLT4
117 chronic venous insufficiency 10.0 VEGFA MTHFR
118 venous insufficiency 10.0 VEGFA MTHFR
119 blood protein disease 10.0 VEGFA MTHFR
120 childhood acute lymphocytic leukemia 10.0 VEGFA MTHFR
121 breast carcinoma in situ 10.0 VEGFA FLT4
122 nephrosclerosis 10.0 VEGFA MTHFR
123 vein disease 10.0 VEGFA MTHFR
124 differentiated thyroid carcinoma 10.0 VEGFA MTHFR
125 chronic mountain sickness 10.0 VEGFA NOS3
126 acute mountain sickness 10.0 VEGFA NOS3
127 background diabetic retinopathy 10.0 VEGFA NOS3
128 buerger disease 10.0 NOS3 MTHFR
129 gastroschisis 10.0 NOS3 MTHFR
130 diabetic polyneuropathy 10.0 VEGFA NOS3
131 acute chest syndrome 10.0 VEGFA NOS3
132 persistent fetal circulation syndrome 10.0 VEGFA NOS3
133 hepatopulmonary syndrome 10.0 VEGFA NOS3
134 blood coagulation disease 10.0 VEGFA MTHFR
135 leukostasis 10.0 VEGFA NOS3
136 diabetic angiopathy 10.0 NOS3 MTHFR
137 achondroplasia 10.0
138 pseudohypoparathyroidism, type ia 10.0
139 chiari malformation type i 10.0
140 diabetes insipidus, nephrogenic, autosomal 10.0
141 dystonia 12 10.0
142 hemifacial atrophy, progressive 10.0
143 hypertension, essential 10.0
144 keratitis, hereditary 10.0
145 marfan syndrome 10.0
146 otitis media 10.0
147 parkinson disease, late-onset 10.0
148 arterial tortuosity syndrome 10.0
149 congenital heart defects, hamartomas of tongue, and polysyndactyly 10.0
150 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.0
151 mucopolysaccharidosis, type vi 10.0
152 persistent mullerian duct syndrome, types i and ii 10.0
153 tardive dyskinesia 10.0
154 apraxia of eyelid opening 10.0
155 hypertension, diastolic 10.0
156 respiratory rhythmicity in sleep 10.0
157 diabetes mellitus, ketosis-prone 10.0
158 pseudopseudohypoparathyroidism 10.0
159 leukemia, acute lymphoblastic 3 10.0
160 hydrops, lactic acidosis, and sideroblastic anemia 10.0
161 mucopolysaccharidosis-plus syndrome 10.0
162 persistent mullerian duct syndrome 10.0
163 segmental dystonia 10.0
164 spasmodic dystonia 10.0
165 sexual disorder 10.0
166 apraxia 10.0
167 isolated ectopia lentis 10.0
168 monocular esotropia 10.0
169 suppression amblyopia 10.0
170 amblyopia 10.0
171 abducens nerve disease 10.0
172 amnestic disorder 10.0
173 social phobia 10.0
174 aseptic meningitis 10.0
175 polyneuropathy 10.0
176 generalized anxiety disorder 10.0
177 hypothyroidism 10.0
178 ectropion 10.0
179 rheumatic disease 10.0
180 mental depression 10.0
181 facial hemiatrophy 10.0
182 status epilepticus 10.0
183 epilepsy 10.0
184 optic nerve disease 10.0
185 hyperostosis 10.0
186 constipation 10.0
187 spondylolysis 10.0
188 hemangioma 10.0
189 cystadenoma 10.0
190 hepatic vascular disease 10.0 VEGFA NOS3
191 grade iii astrocytoma 10.0
192 cerebellopontine angle tumor 10.0
193 demyelinating disease 10.0
194 bone inflammation disease 10.0
195 hyperglycemia 10.0
196 brain stem glioma 10.0
197 foramen magnum meningioma 10.0
198 somatoform disorder 10.0
199 ganglioneuroma 10.0
200 cavernous hemangioma 10.0
201 benign ependymoma 10.0
202 cerebellar astrocytoma 10.0
203 essential tremor 10.0
204 sleep disorder 10.0
205 cellular ependymoma 10.0
206 eye disease 10.0
207 cranial nerve disease 10.0
208 nerve compression syndrome 10.0
209 peripheral nervous system disease 10.0
210 conjunctivitis 10.0
211 petrous apex meningioma 10.0
212 herpes zoster 10.0
213 nervous system disease 10.0
214 lupus erythematosus 10.0
215 parotid gland cancer 10.0
216 diabetes insipidus 10.0
217 exposure keratitis 10.0
218 meningitis 10.0
219 accommodative esotropia 10.0
220 esotropia 10.0
221 lingual-facial-buccal dyskinesia 10.0
222 glossodynia 10.0
223 ocular neuromyotonia 10.0
224 subependymoma 10.0
225 syringobulbia 10.0
226 tuberculous meningitis 10.0
227 hereditary neuropathies 10.0
228 hypertonia 10.0
229 psychogenic movement 10.0
230 combined hyperactive dysfunction syndrome of the cranial nerves 10.0
231 lymphedema 10.0
232 rare tumor 10.0
233 overgrowth syndrome 10.0
234 obsolete: laryngeal dyskinesia 10.0
235 rare movement disorder 10.0
236 marin-amat syndrome 10.0
237 apnea, obstructive sleep 9.9 VEGFA NOS3
238 varicose veins 9.9 VEGFA MTHFR
239 diabetic macular edema 9.9 VEGFA NOS3
240 placenta disease 9.9 VEGFA MTHFR
241 placental abruption 9.9 NOS3 MTHFR
242 varicocele 9.9 NOS3 MTHFR
243 limb ischemia 9.9 VEGFA NOS3
244 pulmonary emphysema 9.9 VEGFA NOS3
245 peripheral artery disease 9.9 VEGFA NOS3
246 homocysteinemia 9.9 NOS3 MTHFR
247 colorectal adenoma 9.9 VEGFA MTHFR
248 exudative vitreoretinopathy 1 9.9 VEGFA NOS3
249 vascular dementia 9.9 VEGFA MTHFR
250 sickle cell anemia 9.9 NOS3 MTHFR
251 methotrexate toxicity 9.8 TYMS MTHFR
252 portal hypertension 9.8 VEGFA NOS3
253 gastroesophageal adenocarcinoma 9.8 TYMS MTHFR
254 adult acute lymphocytic leukemia 9.8 TYMS MTHFR
255 diaphragmatic hernia, congenital 9.8 VEGFA NOS3
256 cardia cancer 9.8 TYMS MTHFR
257 pleural cancer 9.8 VEGFA TYMS
258 migraine with aura 9.8 NOS3 MTHFR
259 cerebral palsy 9.8 NOS3 MTHFR
260 childhood leukemia 9.7 TYMS MTHFR
261 hereditary hemorrhagic telangiectasia 9.7 VEGFA NOS3
262 tetralogy of fallot 9.7 VEGFA MTHFR FLT4
263 hellp syndrome 9.7 VEGFA MTHFR
264 peripheral vascular disease 9.7 VEGFA NOS3
265 malignant pleural mesothelioma 9.7 VEGFA TYMS
266 nonarteritic anterior ischemic optic neuropathy 9.6 VEGFA NOS3 MTHFR
267 carotid stenosis 9.6 VEGFA NOS3 MTHFR
268 osteonecrosis 9.6 VEGFA NOS3 MTHFR
269 retinal vascular disease 9.6 VEGFA NOS3 MTHFR
270 vascular disease 9.6 VEGFA NOS3 MTHFR
271 eclampsia 9.6 VEGFA NOS3 MTHFR
272 chronic kidney disease 9.6 VEGFA NOS3 MTHFR
273 kidney disease 9.6 VEGFA NOS3 MTHFR
274 colorectal adenocarcinoma 9.6 VEGFA TYMS
275 microvascular complications of diabetes 5 9.5 VEGFA NOS3
276 pre-eclampsia 9.5 VEGFA NOS3 MTHFR
277 mucositis 9.5 VEGFA TYMS MTHFR
278 gastric adenocarcinoma 9.4 VEGFA TYMS FLT4
279 squamous cell carcinoma, head and neck 9.4 VEGFA TYMS FLT4
280 malaria 9.0 VEGFA TYMS NOS3 MTHFR
281 gastric cancer 8.5 VEGFA TYMS MTHFR FLT4

Graphical network of the top 20 diseases related to Hemifacial Spasm:



Diseases related to Hemifacial Spasm

Symptoms & Phenotypes for Hemifacial Spasm

MGI Mouse Phenotypes related to Hemifacial Spasm:

45 (showing 1, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 liver/biliary system MP:0005370 8.92 FLT4 MTHFR NOS3 VEGFA

Drugs & Therapeutics for Hemifacial Spasm

Drugs for Hemifacial Spasm (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 26, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1 Pharmaceutical Solutions Phase 4
2
Acetylcholine Approved, Investigational Phase 3 51-84-3 187
3 abobotulinumtoxinA Phase 3
4 Acetylcholine Release Inhibitors Phase 3
5 Neurotransmitter Agents Phase 3
6 Neuromuscular Agents Phase 3
7 Cholinergic Agents Phase 3
8 Botulinum Toxins Phase 3
9 Botulinum Toxins, Type A Phase 3
10
Methylcobalamin Approved, Investigational Early Phase 1 13422-55-4
11
Propofol Approved, Investigational, Vet_approved 2078-54-8 4943
12
Desflurane Approved 57041-67-5 42113
13
Zinc Approved, Investigational 7440-66-6 32051
14
tannic acid Approved 1401-55-4
15
Sevoflurane Approved, Vet_approved 28523-86-6 5206
16
Benzocaine Approved, Investigational 1994-09-7, 94-09-7 2337
17 Anesthetics, General
18 Anesthetics, Inhalation
19 Micronutrients
20 Trace Elements
21 Nutrients
22 Zinc Supplement
23 Central Nervous System Depressants
24 Anesthetics
25 Anesthetics, Local
26 Lidocaine, Prilocaine Drug Combination

Interventional clinical trials:

(showing 23, show less)
# Name Status NCT ID Phase Drugs
1 DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMIZED CLINICAL TRIAL OF THE SAFETY AND EFFICACY OF BOTULINUM TOXIN TYPE A (BOTOX) IN BRUXISM Unknown status NCT00908050 Phase 4 Botulinum toxin type A
2 The Impact of Botulinum Toxin Injection in the Frontalis on Brow Height and Morphology: A Randomized Trial Unknown status NCT03186001 Phase 4 Abobotulinum toxin A
3 Pretarsal Versus Preseptal Botulinum Toxin for Patients With Eyelid Spasm: a Randomized, Triple-blind, Placebo-controlled, Cross-over Clinical Trial Completed NCT03508882 Phase 4 Botulinum Toxin Type A 100Unit/Vial (Product);Saline Solution for Injection
4 A Phase III, Multicentre, Randomised, Assessor-blind, Parallel Groups, Reference Drug Controlled Study to Assess the Efficacy and Safety of a Single Administration, by Subcutaneous Injection of Dysport® for the Treatment of Hemifacial Spasm Completed NCT00276315 Phase 3
5 A 48-Week Prospective, Double-Blinded, Randomized, Cross-over Design in Multicenter Study of 250 Unit of Dysport Versus 50 Unit of Neuronox Injection For Cervical Dystonia in Thai Patients Recruiting NCT03805152 Phase 3 Neuronox(R);Dysport (R)
6 Effect on Tear Functions of Pretarsal and Preseptal Techniques of Botulinum Toxin Type A Injection in Hemifacial Spasm Unknown status NCT01564979 Phase 2 preseptal injection of botulinum toxin type A;pretarsal injection of Botulinum toxin type A
7 Does Bilateral Botulinum Toxin A in Patients With Hemifacial Spasm Improve Facial Symmetry Unilateral and Bilateral Injection of Botulinum Toxin A in Patients With Hemifacial Spasm? A Prospective, Randomized, Controlled Study Unknown status NCT03306940 Botulinum Toxin Type A
8 Observation of the Abnormal Potential From the Offending Vessel to the Facial Muscles of Hemifacial Spasm Patients Unknown status NCT01271634
9 The Research of Autologous Adipose Mesenchymal Stem Cell Transplantation for Treatment of Facial 、Auditory Nerve Dysfunction of Patients With Hemifacial Spasm After Microvascular Decompression. Unknown status NCT02853942 Early Phase 1 Mecobalamin
10 Investigating the Etiology of Hemifacial Spasm (HFS): The Role of Desflurane Unknown status NCT01726725 desflurane
11 The Effect of Zinc Supplementation on the Efficacy and Duration of Botulinum Toxin for the Treatment of Oculofacial Spasm Disorders Unknown status NCT01546805 Zinc Supplement;Sugar pill
12 A Randomised Controlled Trial to Explore the Effectiveness and Cost-effectiveness of a Patient-initiated Botulinum Toxin Treatment Model for Blepharospasm and Hemifacial Spasm Compared to Treatment as Usual Unknown status NCT02577224
13 Microvascular Decompression for HELPS Syndrome: What is the Best Diagnostic Test? Unknown status NCT03126955
14 Effect of Hemifacial Spasm on Intraocular Pressure Measurement Completed NCT03390803
15 A Multicenter, Observational Study to Evaluate Clinical Manifestation, Diagnosis and Treatment of Primary Hemifacial Spasm in Chinese Patients Completed NCT01728428
16 Movement Disorder Survey in East China Completed NCT01168388
17 A Post Marketing Surveillance Study of Dysport Formulated With a Batch of Bulk Active Substance From a New Primary Manufacturing Facility at the Centre for Applied Microbiology & Research. Completed NCT00210431
18 Determination of Target of Adequate Partial Neuromuscular Blockade With Sevoflurane Anesthesia for Electrophysiologic Monitoring During Microvascular Decompression Surgery Completed NCT01613781
19 Determination of Target of Adequate Partial Neuromuscular Blockade for Electrophysiologic Monitoring During Microvascular Decompression Surgery Completed NCT01598961
20 Effect of Acupuncture on Inflammation and Immune Function After Craniotomy Completed NCT02761096
21 Assessment The Effects of Proprioceptive Neuromuscular Facilitation, Myofascial Releasing Maneuvers and Home Exercises on Pain and Jaw Function in Patients With Bruxism Completed NCT03499665
22 Jitter's Recording in a Spastic Muscle Treated by Botulinum Toxin Recruiting NCT04002843
23 CSF Leak Following Microvascular Decompression: the Benefit of Routine Postoperative Lumbar Tap Withdrawn NCT01932255

Search NIH Clinical Center for Hemifacial Spasm

Genetic Tests for Hemifacial Spasm

Genetic tests related to Hemifacial Spasm:

# Genetic test Affiliating Genes
1 Hemifacial Spasm 29

Anatomical Context for Hemifacial Spasm

MalaCards organs/tissues related to Hemifacial Spasm:

40
Eye, Brain, Bone, Testes, Heart, Kidney, Skin

Publications for Hemifacial Spasm

Articles related to Hemifacial Spasm:

(showing 1945, show less)
# Title Authors PMID Year
1
Flanker Task Performance in Isolated Dystonia (Blepharospasm): A Focus on Sequential Effects. 61
32024200 2020
2
Neurotologic Complications Following Microvascular Decompression: A Retrospective Study. 61
32021748 2020
3
Role of Fused Three-Dimensional Time-of-Flight Magnetic Resonance Angiography and 3-Dimensional T2-Weighted Imaging Sequences in Neurovascular Compression. 61
31493603 2020
4
Comments on: Ocular surface status in patients with hemifacial spasm under long-lasting treatment with botulinum A toxin: A comparative fellow eye study. 61
31856551 2020
5
Response to comments on: Ocular surface status in patients with hemifacial spasm under long-lasting treatment with botulinum A toxin: A comparative fellow eye study. 61
31856552 2020
6
Corrigendum to 'Missed Culprits in Failed Microvascular Decompression Surgery for Hemifacial Spasm and Clinical Outcomes of Redo Surgery' [World Neurosurgery 129 (2019) e627-e633]. 61
31680047 2020
7
Using strength-duration analysis to identify the afferent limb of the lateral spread response in hemifacial spasm patients during microvascular decompression surgery. 61
31973918 2020
8
Gamma knife surgery in the treatment of intracanalicular vestibular schwannomas. 61
31922606 2020
9
Strengthened thalamoparietal functional connectivity in patients with hemifacial spasm: a cross-sectional resting-state fMRI study. 61
31904268 2020
10
Prognostic value of abnormal muscle response during microvascular decompression for hemifacial spasm: a meta-analysis. 61
32006731 2020
11
Arachnoid bands and venous compression as rare causes of hemifacial spasm: analysis of etiology in 353 patients. 61
31754846 2020
12
Loop characteristics and audio-vestibular symptoms or hemifacial spasm: is there a correlation? A multiplanar MRI study. 61
31338653 2020
13
Ameliorating Effect of Microvascular Decompression on Patients with Coexistence of Hemifacial Spasm and Glossopharyngeal Neuralgia: A Retrospective Study. 61
31442648 2020
14
Clinical characteristics of petrosal cholesteatoma and value of MRI-DWI in the diagnosis. 61
31876216 2019
15
Preservation of the Lesser Occipital Nerve Prevents Occipital Sensory Disturbance After Microvascular Decompression: Long-Term Results. 61
31843728 2019
16
Extradural Transjugular Transsigmoid Approach with High Cervical Exposure for Glomus Jugulare Tumor. 61
31750071 2019
17
Acupuncture therapy for patients with hemifacial spasm: A protocol of systematic review and meta-analysis. 61
31860984 2019
18
Analysis of blink activity and anomalous eyelid movements in patients with hemifacial spasm. 61
31863396 2019
19
More than hemifacial spasm? A case of unilateral facial spasms with systematic review of red flags. 61
31683060 2019
20
Hypertension and Diabetes are Associated With Clinical Characteristics in Patients Undergoing Microvascular Decompression for Hemifacial Spasm. 61
31842083 2019
21
Prognostic value of lateral spread response during microvascular decompression for hemifacial spasm. 61
30982379 2019
22
Abnormal brain white matter in patients with hemifacial spasm: a diffusion tensor imaging study. 61
31792569 2019
23
Arterial Sling Decompression for Hemifacial Spasm. 61
31470160 2019
24
Can the Jankovic-assessment be used as an alternative to electromyography? A cross-sectional study on facial dystonia patients treated with Botulinum toxin. 61
31477366 2019
25
Long-term Safety and Dosing of OnabotulinumtoxinA: A Prospective, Observational Study. 61
31256770 2019
26
Microvascular decompression in patients with hemifacial spasm. 61
31617334 2019
27
Trigeminal neuralgia plus hemifacial spasm caused by a dilated artery: a case of painful tic convulsif syndrome. 61
31741455 2019
28
Clinical Outcome After Microvascular Decompression According to the Progression Rates of Hemifacial Spasm. 61
31734426 2019
29
Surgical Outcomes of Revision Microvascular Decompression for Persistent or Recurrent Hemifacial Spasm After Surgery: Analysis of Radiologic and Intraoperative Findings. 61
31382068 2019
30
Prosthesis Used in Microvascular Decompressions: A Multicenter Survey in Japan Focusing on Adverse Events. 61
31207376 2019
31
Vascular Complications in Microvascular Decompression: A Survey of 4000 Operations. 61
31254687 2019
32
The long-term effects of microvascular decompression on social phobia and health-related quality of life in patients with hemifacial spasm: a 3-year prospective study. 61
31368052 2019
33
Outcomes and Safety of Overlapping Surgery in Patients Undergoing Microvascular Decompression for Hemifacial Spasm and Trigeminal Neuralgia. 61
31323398 2019
34
Clinical Research on Delayed Cure after Microvascular Decompression for Hemifacial Spasm. 61
31600810 2019
35
AMR monitoring in microvascular decompression for hemifacial spasm: 115 cases report. 61
31648966 2019
36
An Intraoperative Multibranch Abnormal Muscle Response Monitoring Method During Microvascular Decompression for Hemifacial Spasm. 61
31639503 2019
37
Short-term versus long-term outcomes of microvascular decompression for hemifacial spasm. 61
31392569 2019
38
Different Roles of Microvascular Decompression in Hemifacial Spasm and Trigeminal Neuralgia. 61
31534894 2019
39
Hemifacial Spasm Caused by Small Epidermoid Tumor, Misinterpreted as Delayed Secondary Hemifacial Spasm Caused by Vestibular Schwannoma Treated with Gamma Knife Surgery. 61
31349082 2019
40
Ocular surface status in patients with hemifacial spasm under long-lasting treatment with botulinum A toxin: A comparative fellow eye study. 61
31436182 2019
41
Consensus of the Iberoamerican Oculoplastic Society for diagnosis and management of facial dystonia. 61
31272707 2019
42
Combined Hyperactive Dysfunction Syndrome of the Cranial Nerves: Analysis of 37 Cases and Literature Review. 61
31158546 2019
43
[Application of complete endoscopic technique in microvascular decompression related tovertebrobasilar artery compression]. 61
31510719 2019
44
Validation of the Hemifacial Spasm Grading Scale: a clinical tool for hemifacial spasm. 61
31076941 2019
45
Clinical analysis of repeat microvascular decompression for recurrent hemifacial spasm. 61
30963475 2019
46
Comparison of techniques of botulinum toxin injections for blepharospasm and hemifacial spasm. 61
31251420 2019
47
Missed Culprits in Failed Microvascular Decompression Surgery for Hemifacial Spasm and Clinical Outcomes of Redo Surgery. 61
31158550 2019
48
Endovascular Flow Diversion for Hemifacial Spasm Induced by a Vertebral Artery Aneurysm: First Experience. 61
30476260 2019
49
A Rare Potential Compression Can Be Avoided by Lateral Spread Response Recordings During Microvascular Decompression for Hemifacial Spasm. 61
30921064 2019
50
Surgical effect and electrophysiological study of patients with hemifacial spasm treated with botulinum toxin or acupuncture before microvascular decompression. 61
31351214 2019
51
Polytetrafluoroethylene granuloma-associated facial palsy following microvascular decompression. 61
31471979 2019
52
Adverse Events After Microvascular Decompression: A National Surgical Quality Improvement Program Analysis. 61
31082546 2019
53
Brainstem lesion causing paroxysmal ataxia, dysarthria, diplopia and hemifacial spasm (PADDHS). 61
31371274 2019
54
Orbicularis Oculi Morphological Alterations in Affected and Nonaffected Sides in Hemifacial Spasm. 61
31453923 2019
55
Delayed hearing loss after microvascular decompression for hemifacial spasm-an unsolved conspiracy of the cochlear apparatus. 61
31152242 2019
56
Delayed Facial Palsy After Microvascular Decompression for Hemifacial Spasm. 61
31465849 2019
57
Utilization of 3D imaging reconstructions and assessment of symptom-free survival after microvascular decompression of the facial nerve in hemifacial spasm. 61
31299649 2019
58
A Unique Case of Microvascular Triple Decompression for Combined Simultaneous Trigeminal Neuralgia, Hemifacial Spasm, and Glossopharyngeal Neuralgia Because of the Dolichoectatic Vertebrobasilar System. 61
31334555 2019
59
How I do it: 3D exoscopic endoscope-assisted microvascular decompression. 61
31144166 2019
60
In vitro and in vivo experiments of a novel intra-arterial neurovascular decompressor for treating neurovascular compression syndromes: a brief report. 61
31044660 2019
61
"Contralateral Dry Eye in Hemifacial Spasm:" A New Clinical Sign. 61
31497150 2019
62
Intraoperative Neurophysiological Monitoring during Microvascular Decompression Surgery for Hemifacial Spasm. 61
31290293 2019
63
Endoscope-assisted retrosigmoid approach in hemifacial spasm: our experience. 61
29784621 2019
64
Evaluation of Corneal Morphology in Patients With Hemifacial Spasm. 61
30946064 2019
65
A rare case of unilateral hemifacial spasm and facial palsy associated with an abnormal anatomical variant of the posterior basilar circulation. 61
31155905 2019
66
A charcot-marie-tooth type 1B kindred associated with hemifacial spasm and trigeminal neuralgia. 61
30920665 2019
67
Treatment of Venous Hemorrhage Between Vestibulocochlear Nerve and Hypertrophic Flocculus During Microvascular Decompression Procedure for Hemifacial Spasm. 61
31299771 2019
68
Long-term Outcomes of Microvascular Decompression in the Treatment of Hemifacial Spasm Based on Different Offending Vessels. 61
31018226 2019
69
Transposition of the Culprit Artery Passing Between the Facial Nerve and Auditory Nerve in Microvascular Decompression Surgery for Hemifacial Spasm. 61
30974269 2019
70
Wedge-technique for transposition of the vertebral artery in microvascular decompression for hemifacial spasm: technical nuances and surgical outcomes. 61
31028460 2019
71
[Botulinumtoxin in Ophthalmology]. 61
30999362 2019
72
A Meta-Analysis of Endoscopic Microvascular Decompression versus Microscopic Microvascular Decompression for the Treatment for Cranial Nerve Syndrome Caused by Vascular Compression. 61
30776512 2019
73
Absence of Ischemic Injury after Sacrificing the Superior Petrosal Vein during Microvascular Decompression. 61
31214696 2019
74
Retrosigmoid Craniotomy for the Removal of Left Sided Tentorial and Posterior Fossa Meningioma Combined with Microvascular Decompression for Hemifacial Spasm. 61
31143598 2019
75
Endoscopic-Assisted Microvascular Decompression of Ectatic Vertebral Artery for Hemifacial Spasm: Operative Video and Technical Nuances. 61
31143608 2019
76
Lateral Basal Approach to CPA in Supine No-Retractor Method: Microvascular Decompression for Hemifacial Spasm. 61
31143611 2019
77
[Clinical study of microvascular decompression in patients with coexistent hemifacial spasm and ipsilateral trigeminal neuralgia]. 61
31207692 2019
78
The Cornerstone Technique of Microvascular Decompression for Hemifacial Spasm with Vertebral Artery Offender. 61
30743039 2019
79
Hemifacial spasm in sleep - A polysomnographic study. 61
30902436 2019
80
Blink synkinesis monitoring during microvascular decompression for hemifacial spasm. 61
30946116 2019
81
Writing, reading, and speaking in blepharospasm. 61
30783748 2019
82
Pseudoaneurysm presenting around polytetrafluoroethylene fiber following microvascular decompression: A case report and literature review. 61
30732984 2019
83
Preliminary Study on the Relationship Between Inflammation and Hemifacial Spasm. 61
30684712 2019
84
Surgical Treatment of Secondary Hemifacial Spasm: Long-Term Follow-Up. 61
30579009 2019
85
[Study on the relationship between preoperative evaluation, operation and prognosis of microvascular decompression for the treatment of hemifacial spasm]. 61
31091581 2019
86
Algorithm to Predict the Outcome of Microvascular Decompression for Hemifacial Spasm: A Data-Mining Analysis Using a Decision Tree. 61
30738936 2019
87
Treatment of Venous Hemorrhage Between Vestibulocochlear Nerve and Hypertrophic Flocculus During Microvascular Decompression Procedure for Hemifacial Spasm. 61
31022133 2019
88
A correlative analysis between inflammatory cytokines and trigeminal neuralgia or hemifacial spasm. 61
30612530 2019
89
[Clinical application of endoscope combined with microscope for the microvascular decompression in hemifacial spasm]. 61
30991776 2019
90
[Therapy of Hemifacial Spasm with Botulinum Toxin]. 61
30968378 2019
91
Cervical Myelopathy Due to Direct Cord Compression by Posterior Inferior Cerebellar Artery Associated with Aberrant Vertebral Artery. 61
30579018 2019
92
Long-term outcome of flexible onabotulinum toxin A treatment in facial dystonia. 61
30202071 2019
93
Synchronous bilateral hemifacial spasm: case-report and literature review. 61
30511142 2019
94
Delayed hearing loss after microvascular decompression for hemifacial spasm. 61
30569226 2019
95
Evaluation of stigmatization in hemifacial spasm and quality of life before and after botulinum toxin treatment. 61
30178181 2019
96
Hemifacial spasm and vestibular paroxysmia: Co-presence of two neurovascular compression syndromes in a patient. 61
27776966 2019
97
Movement disorders in early MS and related diseases: A prospective observational study. 61
30859004 2019
98
A history of the Jannetta procedure. 61
30717044 2019
99
Clocking tinnitus: An audiology symptom of migraine. 61
30616085 2019
100
Retrosigmoid Intradural Temporal Bone Drilling for Intrapetrous Chondrosarcoma Extending to Cerebellopontine Angle. 61
31108064 2019
101
Intraoperative Measuring of the Offending Vessel's Pressure on the Facial Nerve at Root Exit Zone in Patients with Hemifacial Spasm During Microvascular Decompression: A Prospective Study. 61
30261393 2019
102
Nervus Intermedius Section to Mobilize the Anterior Inferior Cerebellar Artery in Microvascular Decompression Surgery for Hemifacial Spasm: A Technical Case Report. 61
30476669 2019
103
Mobilization of the Anterior/Posterior Inferior Cerebellar Artery on the Cerebellar Surface in Microvascular Decompression Surgery for Hemifacial Spasm: Potential Effect on Hearing Preservation. 61
29790978 2019
104
Revision Microvascular Decompression for Trigeminal Neuralgia and Hemifacial Spasm: Factors Associated with Surgical Failure. 61
30733898 2019
105
"Macrovascular" Decompression of Dolichoectatic Vertebral Artery Causing Hemifacial Spasm Using Goretex Sling: 2-Dimensional Operative Video. 61
29790968 2019
106
Hemifacial Spasm Caused by Vascular Compression in the Cisternal Portion of the Facial Nerve: Report of Two Cases with Review of the Literature. 61
30713778 2019
107
Preoperative Imaging and Microscopic Navigation During Surgery Can Avoid Unnecessarily Opening the Mastoid Air Cells Through Craniotomy Using the Retrosigmoid Approach. 61
30189308 2019
108
Macrovascular Decompression of Facial Nerve With Anteromedial Transposition of a Dolichoectatic Vertebral Artery: 3-Dimensional Operative Video. 61
29788154 2019
109
Trigeminal Nerve Compression Without Trigeminal Neuralgia: Intraoperative vs Imaging Evidence. 61
29425330 2019
110
Risk factors for postoperative delirium in patients undergoing microvascular decompression. 61
30998697 2019
111
Endoscope-Assisted Microneurosurgery for Neurovascular Compression Syndromes: Basic Principles, Methodology, and Technical Notes. 61
30937034 2019
112
Effect of Botulinum toxin A application in neuro-ophtalmologic indications on Schirmers test and tears osmolarity. 61
31537075 2019
113
Functional Movement Disorders in Elderly. 61
31413900 2019
114
Nerve Compression Syndromes in the Posterior Cranial Fossa. 61
30855007 2019
115
The Value of Three-Dimensional Brain Volume Combined with Time-of-Flight MRA in Microvascular Decompression. 61
31288239 2019
116
Structural brain network fingerprints of focal dystonia. 61
31798688 2019
117
Microvascular Decompression in Patients Aged 30 Years or Younger. 61
30937020 2019
118
Subcortical Brain Abnormalities and Clinical Relevance in Patients With Hemifacial Spasm. 61
32010045 2019
119
Geographic Disparities in the Surgical Management of Hemifacial Spasm in Canada. 61
30688196 2019
120
Endoscope-Assisted Microvascular Decompression for the Management of Hemifacial Spasm Caused by Vertebrobasilar Dolichoectasia. 61
30278293 2019
121
Botulinum toxin relieves anxiety and depression in patients with hemifacial spasm and blepharospasm. 61
30587995 2019
122
Hemifacial Spasm Caused by Veins Confirmed by Intraoperative Monitoring of Abnormal Muscle Response. 61
31251307 2019
123
Ocular Dyskinesia and Hemifacial Spasm Secondary to Fourth Ventricular Tumor: Report of 4 Cases and Review of the Literature. 61
31437843 2019
124
Microvascular Decompression of Facial Nerve and Pexy of the Left Vertebral Artery for Left Hemifacial Spasm: 3-Dimensional Operative Video. 61
29617905 2019
125
Structural and Functional Amygdala Abnormalities in Hemifacial Spasm. 61
31114534 2019
126
Foreign Body Granuloma After Cranial Surgery: A Systematic Review of Reported Cases. 61
30267951 2018
127
Anatomic Variation and Hemodynamic Evolution of Vertebrobasilar Arterial System May Contribute to the Development of Vascular Compression in Hemifacial Spasm. 61
30593967 2018
128
Facial motor evoked potential with paired transcranial magnetic stimulation: prognostic value following microvascular decompression for hemifacial spasm. 61
30579277 2018
129
Microvascular Decompression for Hemifacial Spasm Associated with Vertebral Artery: Biomedical Glue-Coated Teflon Sling Transposition Technique. 61
30144608 2018
130
Endoscopically Assisted Targeted Keyhole Retrosigmoid Approaches for Microvascular Decompression: Quantitative Anatomic Study. 61
29960095 2018
131
Ring graft technique for microvascular decompression. 61
30504565 2018
132
Comparison of serum concentration of Ca, P, Mg, and Fe between hemifacial spasm patients and healthy controls; prospective randomized controlled study. 61
30417857 2018
133
The Outcome of Sling Retraction Technique in Microvascular Decompression for Hemifacial Spasm. 61
30015734 2018
134
Cavernous angioma of the cerebellopontine angle presenting as hemifacial spasm. 61
30504594 2018
135
The association between auditory nerve neurovascular conflict and sudden unilateral sensorineural hearing loss. 61
30410992 2018
136
Microanatomy Around the Facial Nerve Pathway for Microvascular Decompression Surgery Investigated with Correlative Light Microscopy and Block-Face Imaging. 61
30257305 2018
137
Fully endoscopic microvascular decompression for hemifacial spasm. 61
30497190 2018
138
Involved Small Arteries in Patients Who Underwent Microvascular Decompression for Hemifacial Spasm. 61
30017761 2018
139
Prognosis of Symptoms and Complications After Microvascular Decompression for Hemifacial Spasm: A Single-Center Experience. 61
29981914 2018
140
Retrospective clinical analysis of 320 cases of microvascular decompression for hemifacial spasm. 61
30313020 2018
141
Is hemifacial spasm affected by changes in the heart rate? A study using heart rate variability analysis. 61
30033222 2018
142
Veins of the Cerebellopontine Angle and Specific Complications of Sacrifice, with Special Emphasis on Microvascular Decompression Surgery. A Review. 61
29966798 2018
143
Botulinum neurotoxin for the treatment of movement disorders. 61
30244558 2018
144
Simultaneous supervision by microscope of endoscope-assisted microsurgery via presigmoid retrolabyrinthine approach: A pilot study. 61
30139697 2018
145
Chemodenervation for the Treatment of Facial Dystonia: A Report by the American Academy of Ophthalmology. 61
29653859 2018
146
Hemifacial spasm secondary to vascular loop compression: a rare case report. 61
30484026 2018
147
Botulinum toxin therapy of hemifacial spasm: bilateral injections can reduce facial asymmetry. 61
29987587 2018
148
Hemifacial spasm after eight-and-a-half syndrome. 61
29730020 2018
149
Blepharospasm with elevated anti-acetylcholine receptor antibody titer. 61
30231125 2018
150
Hemifacial Spasm as Rare Clinical Presentation of Vestibular Schwannomas. 61
29852302 2018
151
Delayed facial palsy after microvascular decompression for hemifacial spasm: friend or foe? 61
28862543 2018
152
Letter to the Editor. Delayed facial palsy after microvascular decompression for hemifacial spasm. 61
29749909 2018
153
Édouard Brissaud: distinguished neurologist and Charcot's pupil. 61
30066801 2018
154
A new method for monitoring abnormal muscle response in hemifacial spasm: A prospective study. 61
29625882 2018
155
Severe Hemifacial Spasm is a Predictor of Severe Indentation and Facial Palsy after Microdecompression Surgery. 61
29856152 2018
156
An improved methodology for intraoperative monitoring of the lateral spreading response during surgery for hemifacial spasm. 61
29691117 2018
157
Hemodynamic features of offending vessels at neurovascular contact in patients with trigeminal neuralgia and hemifacial spasm. 61
29979116 2018
158
Clinical features and response to botulinum toxin in primary and secondary hemifacial spasm. 61
30038089 2018
159
Bridging veins and veins of the brainstem in microvascular decompression surgery for trigeminal neuralgia and hemifacial spasm. 61
29961378 2018
160
Hemifacial Spasm Caused by a Vein: A Case Report. 61
30283547 2018
161
Treatment of hemifacial spasm: Botulinum toxin versus microvascular decompression. 61
30038090 2018
162
Gold thread acupuncture for hemifacial spasm. 61
30037913 2018
163
[Botulinum Toxin - New Developments in Ophthalmology]. 61
28114700 2018
164
Hemifacial spasm secondary to middle ear cholesteatoma. 61
30036421 2018
165
Successive occurrence of vertebrobasilar dolichectasia induced trigeminal neuralgia, vestibular paroxysmia and hemifacial spasm: A case report. 61
29924039 2018
166
Intraoperative monitoring of Z-L response (ZLR) and abnormal muscle response (AMR) during microvascular decompression for hemifacial spasm. Interpreting the role of ZLR. 61
29344780 2018
167
Upfront Gamma Knife surgery for facial nerve schwannomas: retrospective case series analysis and systematic review. 61
29492656 2018
168
"Birdlime" technique using TachoSil tissue sealing sheet soaked with fibrin glue for sutureless vessel transposition in microvascular decompression: operative technique and nuances. 61
28799873 2018
169
Gamma Knife radiosurgery for large vestibular schwannomas greater than 3 cm in diameter. 61
28707997 2018
170
Microvascular decompression for hemifacial spasm: Outcome on spasm and complications. A review. 61
29454467 2018
171
Increase lipid tear thickness after botulinum neurotoxin A injection in patients with blepharospasm and hemifacial spasm. 61
29849166 2018
172
Endoscope-assisted decompression of facial nerve for treatment of hemifacial spasm. 61
29705021 2018
173
Multimodal Image-Based Virtual Reality Presurgical Simulation and Evaluation for Trigeminal Neuralgia and Hemifacial Spasm. 61
29476993 2018
174
The conflicting vessels in hemifacial spasm: Literature review and anatomical-surgical implications. 61
29680283 2018
175
The critical warning sign of real-time brainstem auditory evoked potentials during microvascular decompression for hemifacial spasm. 61
29342440 2018
176
Imaging of hemifacial spasm. 61
29705020 2018
177
Diagnosis of primary hemifacial spasm. 61
29673578 2018
178
Surgical anatomy for hemifacial spasm. 61
29779610 2018
179
New insights into the pathophysiology of primary hemifacial spasm. 61
29673579 2018
180
Introduction to primary hemifacial spasm: A neurosurgical disease. 61
29789138 2018
181
Microvascular decompression for hemifacial spasm : Surgical techniques and intraoperative monitoring. 61
29784430 2018
182
Hemifacial spasm associated with other cranial nerve syndromes: Literature review. 61
29680282 2018
183
Prospective and retrospective study of videoconference telemedicine follow-up after elective neurosurgery: results of a pilot program. 61
28735437 2018
184
A comparative study of intraoperative findings and postoperative outcomes between atypical and typical hemifacial spasms. 61
28831592 2018
185
Isolated hemifacial spasm presenting as unilateral, involuntary ear movements. 61
29329937 2018
186
An atypical presentation of hemifacial spasm secondary to neurovascular compression. 61
29554395 2018
187
Microvascular decompression for hemifacial spasm: can intraoperative lateral spread response monitoring improve surgical efficacy? 61
28498061 2018
188
Botulinum toxin therapy in patients with oral anticoagulation: is it safe? 61
29116410 2018
189
Microvascular Decompression for Patients With Hemifacial Spasm Associated With Common Trunk Anomaly of the Cerebellar Arteries-Case Study and Review of Literature. 61
29351689 2018
190
What Should We Do for Those Hemifacial Spasm Patients Without Efficacy Following Microvascular Decompression: Expectation of Delayed Relief or Early Reoperation? 61
29191535 2018
191
Reorganization of sensory input at brainstem in hemifacial spasm and postparalytic facial syndrome. 61
29124438 2018
192
Efficacy of Biomedical Glue Sling Technique Versus Traditional Technique for Microvascular Decompression for Hemifacial Spasm with Refractory Hypertension. 61
29146437 2018
193
Long-Term Outcome of Repeat Microvascular Decompression for Hemifacial Spasm. 61
29203317 2018
194
Botulinum Toxin Treatment of Movement Disorders. 61
29478149 2018
195
The pathogenesis of delayed epidural hematoma after posterior fossa surgery. 61
29037935 2018
196
Hearing Loss following Posterior Fossa Microvascular Decompression: A Systematic Review. 61
28895459 2018
197
Microvascular decompression for glossopharyngeal neuralgia: a retrospective analysis of 228 cases. 61
29103137 2018
198
Blepharospasm and Hemifacial Spasm. 61
29239872 2018
199
Facial Myokymia and Hemifacial Spasm in Multiple Sclerosis: A Descriptive Study on Clinical Features and Treatment Outcomes. 61
29266036 2018
200
Neurological Imaging for Hemifacial Spasm. 61
29239882 2018
201
Microvascular Decompression for Hemifacial Spasm. 61
29239883 2018
202
Botulinum Toxins for Treating Essential Blepharospasm and Hemifacial Spasm. 61
29239877 2018
203
Surgical Myectomy for Essential Blepharospasm and Hemifacial Spasm. 61
29239878 2018
204
Effect of Hemifacial Spasm on Intraocular Pressure Measurement. 61
29545951 2018
205
Hemifacial Spasm in Mucopolysaccharidosis Type VI (Maroteaux-Lamy Syndrome). 61
29971196 2018
206
Surgical management of coexisting trigeminal neuralgia and hemifacial spasm. 61
30488012 2018
207
Quantitative study of the correlation between cerebellar retraction factors and hearing loss following microvascular decompression for hemifacial spasm. 61
29075904 2018
208
Prosthetic material degeneration over time as a possible factor in delayed recurrence of hemifacial spasm after successful microvascular decompression. 61
30283720 2018
209
Long-Term Efficacy of Initial Microvascular Decompression Versus Subsequent Microvascular Decompression for Idiopathic Hemifacial Spasm. 61
29074421 2018
210
How I do it: endoscopic microvascular decompression for hemifacial spasm associated with the vertebral artery. 61
29143107 2018
211
An investigation into quality of life improvement in patients undergoing microvascular decompression for hemifacial spasm. 61
28186450 2018
212
[Application of the supine position in microsurgery for lesions of the cerebellopontine angle]. 61
29275608 2017
213
Hearing Outcome Following Microvascular Decompression for Hemifacial Spasm: Series of 1434 Cases. 61
28927910 2017
214
The Effects of Combined Intraoperative Monitoring of Abnormal Muscle Response and Z-L Response for Hemifacial Spasm. 61
28882717 2017
215
Spastic paretic hemifacial contracture related to multiple sclerosis: a rare and under-recognized entity. 61
28730530 2017
216
Application of Ion-beam Implanted Expanded Polytetrafluoroethylene to Microvascular Decompression and the Surgical Outcome. 61
28954963 2017
217
A comparative crossover study on the treatment of hemifacial spasm and blepharospasm: preseptal and pretarsal botulinum toxin injection techniques. 61
28884242 2017
218
A New Score to Predict the Risk of Hearing Impairment After Microvascular Decompression for Hemifacial Spasm. 61
28973677 2017
219
Operative Complications of Microvascular Decompression for Hemifacial Spasm: Experience of 1548 Cases. 61
28823667 2017
220
Surgical Management of Hemifacial Spasm Associated with Chiari I Malformation: Analysis of 28 Cases. 61
28823670 2017
221
Improvement of Quality of Life in Patients with Hemifacial Spasm After Microvascular Decompression: A Prospective Study. 61
28826863 2017
222
Microvascular Decompression for Trigeminal Neuralgia Using a Novel Fenestrated Clip and Tentorial Flap Technique. 61
28754638 2017
223
Cochlear Nerve Action Potential Monitoring for Preserving Function of an Unseen Cochlear Nerve in Vestibular Schwannoma Surgery. 61
28755914 2017
224
Evaluating the effects of Botulinum Toxin A on tear metrics in patients with hemifacial spasm. 61
28627956 2017
225
Botulinum toxin A is effective to treat tension-type headache caused by hemifacial spasm. 61
28734794 2017
226
[Investigation of short-term resolution as a predictor of long-term cure of microvascular decompression in hemifacial spasm]. 61
29081153 2017
227
Treatment of hemifacial spasm in patient with hemifacial atrophy using combination therapy (ultrasound therapy and TENS): a case report. 61
29123626 2017
228
Teaching Video NeuroImages: Hemifacial spasm due to cerebellopontine angle mass. 61
29084931 2017
229
Psychogenic Movement Disorders in Adults and Children: A Clinical and Video Profile of 58 Indian Patients. 61
30868096 2017
230
Deterministic Tractography of the Descending Tract of the Spinal Trigeminal Nerve Using Diffusion Tensor Imaging. 61
28140499 2017
231
Microvascular decompression for hemifacial spasm associated with the vertebral artery. 61
28332169 2017
232
The Effect of Microvascular Decompression on Hemifacial Spasm With Atherosclerosis of Vertebral Artery. 61
28749841 2017
233
Treatment of Blepharospasm/Hemifacial Spasm. 61
28965229 2017
234
Treatment of Posterior Inferior Cerebellar Artery Adhesion on Petrous Bone During Microvascular Decompression Procedure for Hemifacial Spasm: Technique Note. 61
28863115 2017
235
Surgical Treatment of Hemifacial Spasm Caused by the Compression of Internal Auditory Canal of Facial Nerve. 61
28796106 2017
236
Results of Atypical Hemifacial Spasm with Microvascular Decompression: 14 Case Reports and Literature Review. 61
28619495 2017
237
Combined Hyperactive Dysfunction Syndrome of the Cranial Nerves: A Retrospective Systematic Study of Clinical Characteristics in 44 Patients. 61
28512048 2017
238
Ectopic cerebellar tissue in the occipital bone: a case report. 61
28823247 2017
239
Anterior Inferior Cerebellar Arteries Juxtaposed with the Internal Acoustic Meatus and Their Relationship to the Cranial Nerve VII/VIII Complex. 61
29057182 2017
240
Bilateral painful tic convulsif. 61
28801514 2017
241
Outcome of Biomedical Glue Sling Technique in Microvascular Decompression for Hemifacial Spasm Involving the Vertebral Artery. 61
28434962 2017
242
[The study of hearing loss after microvascular decompression for hemifacial spasm]. 61
28835048 2017
243
Role of the "other Babinski sign" in hyperkinetic facial disorders. 61
28566174 2017
244
Delayed Facial Palsy after Microvascular Decompression: Report of Two Cases. 61
28694636 2017
245
The Multiscope Technique for Microvascular Decompression. 61
28434953 2017
246
Paget's Disease of the Temporal Bone: A Single-Institution Contemporary Review of 27 Patients. 61
28498272 2017
247
Fatal complications following microvascular decompression: could it be avoided and salvaged? 61
27734209 2017
248
Teflon granuloma after microvascular decompression for hemifacial spasm: a case report and literature review. 61
28534142 2017
249
Early permanent disappearance of abnormal muscle response during microvascular decompression for hemifacial spasm: a retrospective clinical study. 61
27981401 2017
250
Utility of the intensive care unit in patients undergoing microvascular decompression: a multiinstitution comparative analysis. 61
27518528 2017
251
Electromyographically Guided Nerve Combing Makes Microvascular Decompression More Successful in Hemifacial Spasm with Persistent Abnormal Muscle Response. 61
28254601 2017
252
[A Case of Coexistent Glossopharyngeal Neuralgia and Hemifacial Spasm Successfully Treated with Transposition of the Vertebral Artery]. 61
28634310 2017
253
Correlation Between Cerebellar Retraction and Hearing Loss After Microvascular Decompression for Hemifacial Spasm: A Prospective Study. 61
28286281 2017
254
Prevalence of Bruxism in Hemifacial-Spasm Patients. 61
26588188 2017
255
Long-term outcome of microvascular decompression for hemifacial spasm. 61
28288523 2017
256
Persistent hemifacial spasm after microvascular decompression: a risk assessment model. 61
27906546 2017
257
The association between vertebrobasilar dolichoectasia and hemifacial spasm: Historical perspective. 61
28274678 2017
258
Hemifacial spasm and neurovascular compression syndrome. 61
28500109 2017
259
The association between vertebrobasilar dolichoectasia and hemifacial spasm: Reply to comments. 61
28237851 2017
260
Endoscopic Microvascular Decompression with Transposition for Trigeminal Neuralgia and Hemifacial Spasm: Technical Note. 61
27595274 2017
261
The Effects of Dual Abnormal Muscle Response Monitoring on Microvascular Decompression in Patients with Hemifacial Spasm. 61
28153619 2017
262
Microvascular decompression for hemifacial spasm: A systematic review of vascular pathology, long term treatment efficacy and safety. 61
28488609 2017
263
Cluster Headache Associated with Secondary Unilateral Blepharospasm: A Case Report and Review of the Literature. 61
28540017 2017
264
The Current Status of Microvascular Decompression for the Treatment of Hemifacial Spasm in Japan: An Analysis of 2907 Patients Using the Japanese Diagnosis Procedure Combination Database. 61
28179598 2017
265
Hemifacial spasm associated with type 1 Chiari malformation: a retrospective study of 13 cases. 61
27422274 2017
266
Outcome of microvascular decompression for hemifacial spasm associated with the vertebral artery. 61
27278791 2017
267
Health-related quality of life outcomes from botulinum toxin treatment in hemifacial spasm. 61
28507604 2017
268
[Therapy of Hemifacial Spasm with Botulinum Toxin]. 61
28437820 2017
269
[An unusual presentation of painful tic convulsive]. 61
28272727 2017
270
[Intraoperative Artery Wall Stimulating Electromyography during Microvascular Decompression Surgery to Treat Hemifacial Spasm:A Case Report]. 61
28297691 2017
271
Teflon granulomas mimicking cerebellopontine angle tumors following microvascular decompression. 61
27320780 2017
272
Supratentorial acute subdural haematoma during microvascular decompression surgery: report of three cases. 61
28740635 2017
273
Factors Promoting a Good Outcome in a Second Microvascular Decompression Operation When Hemifacial Spasm is Not Relieved After the Initial Operation. 61
27923748 2017
274
Brainstem Auditory Evoked Potentials' Diagnostic Accuracy for Hearing Loss: Systematic Review and Meta-Analysis. 61
28180042 2017
275
Intermittent facial spasms as the presenting sign of a recurrent pleomorphic adenoma. 61
28246588 2017
276
Familial hemifacial spasm of young-onset: Report of two cases. 61
28131234 2017
277
Distinguishing features of psychogenic (functional) versus organic hemifacial spasm. 61
27942912 2017
278
A successful treatment of hemifacial spasm coexisted with brainstem cavernoma. 61
27857039 2017
279
Analysis of facial motor evoked potentials for assessing a central mechanism in hemifacial spasm. 61
27177175 2017
280
Treatment of hemifacial spasm with botulinum toxin type a: effective, long lasting and well tolerated. 61
28226076 2017
281
Failed microvascular decompression surgery for hemifacial spasm: a retrospective clinical study of reoperations. 61
27817006 2017
282
What range of stimulus intensities should we apply to elicit abnormal muscle response in microvascular decompression for hemifacial spasm? 61
27783168 2017
283
Evaluating Transient Hemifacial Spasm that Reappears After Microvascular Decompression Specifically Focusing on the Real Culprit Location of Vascular Compression. 61
27832991 2017
284
Prognostic ability of intraoperative electromyographic monitoring during microvascular decompression for hemifacial spasm to predict lateral spread response outcome. 61
27104851 2017
285
An optimized abnormal muscle response recording method for intraoperative monitoring of hemifacial spasm and its long-term prognostic value. 61
28027998 2017
286
Single Neurosurgeon Operative Experience at Craig Joint Theater Hospital During the Afghanistan Surge (November 2010 to April 2011), Part II: Humanitarian Cases. 61
28051982 2017
287
The therapeutic usage of botulinum toxin (Botox) in non-cosmetic head and neck conditions - An evidence based review. 61
28223858 2017
288
Diabetes and morbid obesity are associated with higher reoperation rates following microvascular decompression surgery: An ACS-NSQIP analysis. 61
29184719 2017
289
Economics of botulinum toxin therapy: influence of the abobotulinumtoxinA package size on the costs of botulinum toxin therapy. 61
28465830 2017
290
[Emotional and personality characteristics of patients with dystonia]. 61
29376977 2017
291
Fleece-Bound Tissue Sealing in Microvascular Decompression. 61
27593828 2017
292
Microvascular decompression for hypoglossal nerve palsy secondary to vertebral artery compression: A case report and review of the literature. 61
28584677 2017
293
Five-Year Retrospective Review of Cases with Benign Essential Blepharospasm and Hemifacial Spasm Presenting in a Tertiary Eye Care Center in North India. 61
27078720 2017
294
Gamma knife radiosurgery for cerebellopontine angle epidermoid tumors. 61
29184709 2017
295
Imaging of Vascular Compression Syndromes. 61
27890181 2017
296
Clinical characteristics of arteriovenous malformations in the cerebellopontine angle cistern. 61
27035170 2017
297
Changes in neurotrophic and inflammatory factors in the cerebrospinal fluid of patients with postherpetic neuralgia. 61
27888042 2017
298
The Significance of Abnormal Muscle Response Monitoring During Microvascular Decompression for Hemifacial Spasm. 61
28120087 2017
299
Application of neuroendoscopy in the surgical treatment of complicated hemifacial spasm. 61
28064327 2017
300
Hemifacial Spasm Secondary to Parotid Pleomorphic Adenoma With Stylomastoid Foramen Extension. 61
27755360 2017
301
Natural History of Untreated Hemifacial Spasm: A Study of 104 Consecutive Patients over 5 Years. 61
28088801 2017
302
Lower cranial nerve palsy after the infrafloccular approach in microvascular decompression for hemifacial spasm. 61
28540133 2017
303
Tenth case of bilateral hemifacial spasm treated by microvascular decompression: Review of the pathophysiology. 61
29026661 2017
304
Nonspastic hemifacial spasm confirmed by abnormal muscle responses. 61
28695043 2017
305
Multiple Sclerosis Presenting with Facial Twitching (Myokymia and Hemifacial Spasms). 61
29075542 2017
306
Postparalytic Hemifacial Spasm: A Case Study. 61
28244961 2017
307
Acute clinical adverse radiation effects after Gamma Knife surgery for vestibular schwannomas. 61
27903185 2016
308
Preoperative Evaluation of Patients with Hemifacial Spasm by Three-dimensional Time-of-Flight (3D-TOF) and Three-dimensional Constructive Interference in Steady State (3D-CISS) Sequence. 61
25795466 2016
309
Use of Botulinum Neurotoxin in Ophthalmology. 61
28050326 2016
310
Magnetic Resonance Imaging Assessment of Vascular Contact of the Facial Nerve in the Asymptomatic Patient. 61
27857878 2016
311
Efficacy of levetiracetam in primary hemifacial spasm. 61
27460515 2016
312
Comparison of brain MRI angiography and brain MRI cisternography in patients with hemifacial spasm. 61
26908032 2016
313
[Painful tic convulsif: Case series and literature review]. 61
26774197 2016
314
Use of Alleviating Maneuvers for Periocular Facial Dystonias. 61
27606483 2016
315
Real-time intraoperative monitoring of brainstem auditory evoked potentials during microvascular decompression for hemifacial spasm. 61
26824371 2016
316
Facial asymmetry in patients with hemifacial spasm before and after botulinum toxin A treatment. 61
27431279 2016
317
Hemifacial Spasm From Lyme Disease: Antibiotic Treatment Points to the Cause. 61
27755133 2016
318
Alleviating Maneuvers for Benign Essential Blepharospasm and Hemifacial Spasm. 61
27607413 2016
319
The association between vertebrobasilar dolichoectasia and hemifacial spasm. 61
27567723 2016
320
A significant correlation between delayed cure after microvascular decompression and positive response to preoperative anticonvulsant therapy in patients with hemifacial spasm. 61
27235129 2016
321
Facial synkinesis as a first symptom of multiple sclerosis. 61
26245215 2016
322
An unusual ocular complication following dental anaesthesia: case report. 61
26671751 2016
323
Standardized reporting of adverse events after microvascular decompression of cranial nerves; a population-based single-institution consecutive series. 61
27260489 2016
324
Real-World, Long-Term Quality of Life Following Therapeutic OnabotulinumtoxinA Treatment. 61
27430524 2016
325
Fractionated stereotactic radiation therapy for vestibular schwannomas: Dosimetric factors predictive of hearing outcomes. 61
26961715 2016
326
A Rare Cause of Hemifacial Spasm: Papillary Oncocytic Cystadenoma. 61
27761290 2016
327
Bioglue-Coated Teflon Sling Technique in Microvascular Decompression for Hemifacial Spasm Involving the Vertebral Artery. 61
27651870 2016
328
Facial spasms, but not hemifacial spasm: a case report and review of literature. 61
26984806 2016
329
Increasing the area and varying the dosage of Botulinum toxin a injections for effective treatment of hemifacial spasm. 61
27067535 2016
330
Primary Epidermoid Tumors of the Cerebellopontine Angle: A Review of 47 Cases. 61
27273398 2016
331
Preoperative Three-Dimensional Diagnosis of Neurovascular Relationships at the Root Exit Zones During Microvascular Decompression for Hemifacial Spasm. 61
27178237 2016
332
Significance of Anomalous Anterior Inferior Cerebellar Artery-Posterior Inferior Cerebellar Artery Common Trunk Compression in Microvascular Decompression for Hemifacial Spasm. 61
27155382 2016
333
Imaging of Neurovascular Compression Syndromes: Trigeminal Neuralgia, Hemifacial Spasm, Vestibular Paroxysmia, and Glossopharyngeal Neuralgia. 61
26892985 2016
334
Good Surgical Outcomes of Hemifacial Spasm Patients with Obvious Facial Nerve Indentation and Color Change. 61
27184901 2016
335
Cognitive Flexibility in Primary Dystonia. 61
27333537 2016
336
The value of lateral spread response monitoring in predicting the clinical outcome after microvascular decompression in hemifacial spasm: a prospective study on 100 patients. 61
27053220 2016
337
Erratum to: 'Effectiveness and cost-effectiveness of a patient-initiated botulinum toxin treatment model for blepharospasm and hemifacial spasm compared to standard care: study protocol for a randomised controlled trial'. 61
27439615 2016
338
Corticosteroids for Bell's palsy (idiopathic facial paralysis). 61
27428352 2016
339
The origin of the abnormal muscle response seen in hemifacial spasm remains controversial. 61
27222310 2016
340
Reply to "The origin of the abnormal muscle response seen in hemifacial spasm remains controversial". 61
27189845 2016
341
Vascular tortuosity in relationship with hypertension and posterior fossa volume in hemifacial spasm. 61
27473840 2016
342
Brainstem Developmental Venous Anomaly Causing Hemifacial Spasm - Case Report and Review of the Literature. 61
27133013 2016
343
Placement of Teflon Sponges in Microvascular Decompression Procedure for Treatment of Hemifacial Spasm. 61
25798798 2016
344
Benefits of microvascular decompression on social anxiety disorder and health-related quality of life in patients with hemifacial spasm. 61
27155866 2016
345
Influence of involuntary eyelid spasms on corneal topographic and eyelid morphometric changes in patients with hemifacial spasm. 61
26541432 2016
346
Successful Treatment of Hemifacial Spasm Caused by an Ectatic Vertebral Artery Accompanying Agenesis of the Carotid Artery. 61
28825001 2016
347
Management of symptomatic hemifacial spasm or trigeminal neuralgia. 61
26876893 2016
348
Side predilections of offending arteries in hemifacial spasm. 61
26898581 2016
349
Flatness of the infratentorial space associated with hemifacial spasm. 61
27179978 2016
350
Long-term surgical results in microvascular decompression for hemifacial spasm: efficacy, morbidity and quality of life. 61
27214834 2016
351
Impact of botulinum toxin-A on corneal curvature assessed with Scheimpflug and Placido systems. 61
27255252 2016
352
Ephaptic transmission is the origin of the abnormal muscle response seen in hemifacial spasm. 61
27072096 2016
353
Delayed Facial Palsy After Microvascular Decompression for Hemifacial Spasm. 61
27046467 2016
354
[Microvascular decompression for hemifacial spasm induced by vertebral artery dissecting aneurysm: one case report]. 61
28087915 2016
355
Hemifacial Spasm Associated with Contralateral Foramen Magnum Meningioma. 61
26826538 2016
356
Application of electrophysiological methods and magnetic resonance tomographic angiography in the differentiation between hemifacial spasm and Meige syndrome. 61
26838523 2016
357
Botulinum Toxin and Muscle Atrophy: A Wanted or Unwanted Effect. 61
26780946 2016
358
Tentorial meningioma presenting as hemifacial spasm: An unusual clinical scenario. 61
27057238 2016
359
Hemifacial Spasm in a Child Treated With Microvascular Decompression of the Facial Nerve. 61
26880528 2016
360
Conversion Ratio between Botox®, Dysport®, and Xeomin® in Clinical Practice. 61
26959061 2016
361
Effectiveness and cost-effectiveness of a patient-initiated botulinum toxin treatment model for blepharospasm and hemifacial spasm compared to standard care: study protocol for a randomised controlled trial. 61
26961367 2016
362
Subjective and Objective Measures in the Treatment of Hemifacial Spasm With OnabotulinumtoxinA. 61
25811161 2016
363
Clinical analysis of hemifacial spasm patients with delay symptom relief after microvascular decompression of distinct offending vessels. 61
25894350 2016
364
Management of Bilateral Hemifacial Spasm with Microvascular Decompression. 61
26548830 2016
365
Differences in Corneal Parameters Between Affected and Normal Contralateral Eyes in Patients With Hemifacial Spasm Treated With Botulinum Toxin-A: Outcomes During One Complete Treatment Cycle. 61
26619386 2016
366
Bell's Palsy. 61
26611696 2016
367
Revisiting the link between hypertension and hemifacial spasm. 61
26891766 2016
368
Microvascular decompression for atypical hemifacial spasm: lessons learned from a retrospective study of 12 cases. 61
26339846 2016
369
Prognosis research of delayed facial palsy after microvascular decompression for hemifacial spasm. 61
26659255 2016
370
Structural brain alterations in hemifacial spasm: A voxel-based morphometry and diffusion tensor imaging study. 61
26424116 2016
371
Botulinum Toxin Treatment of Blepharospasm, Orofacial/Oromandibular Dystonia, and Hemifacial Spasm. 61
26866500 2016
372
Considerations on patient-related outcomes with the use of botulinum toxins: is switching products safe? 61
26917963 2016
373
Reappearance of Cranial Nerve Dysfunction Symptoms Caused by New Artery Compression More than 20 Years after Initially Successful Microvascular Decompression: Report of Two Cases. 61
26804190 2016
374
Microvascular Decompression of the Optic Nerve for Paroxysmal Phosphenes and Visual Field Deficit. 61
26459702 2016
375
Healing of Deep Wound Infection without Removal of Non-Absorbable Dura Mater (Neuro-Patch®): A Case Report. 61
27649762 2016
376
Supratentorial subdural hematoma following microvascular decompression: a report of four cases. 61
27066366 2016
377
Remission of neurovascular conflicts in the cerebellopontine angle in interventional neuroradiology. 61
25428450 2016
378
Grey Matter Microstructural Integrity Alterations in Blepharospasm Are Partially Reversed by Botulinum Neurotoxin Therapy. 61
27992533 2016
379
Hemifacial spasm in a patient with basilar artery dolichoectasia caused by uncontrolled hypertension. 61
27802860 2016
380
Sexual Well-Being in Patients with Blepharospasm, Spasmodic Torticollis, and Hemifacial Spasm: A Pilot Study. 61
27761118 2016
381
Postoperative complications of microvascular decompression for hemifacial spasm: lessons from experience of 2040 cases. 61
26382646 2016
382
[Microvascular decompression in hemifacial spasm: 13 cases report and review of the literature]. 61
27127708 2016
383
Failed microvascular decompression surgery for hemifacial spasm due to persistent neurovascular compression: an analysis of reoperations. 61
26295916 2016
384
Vagoglossopharyngeal Neuralgia Occurred Concomitantly with Ipsilateral Hemifacial Spasm and Versive Seizure-Like Movement: A First Case Report. 61
27455832 2016
385
Teflon Might Be a Factor Accounting for a Failed Microvascular Decompression in Hemifacial Spasm: A Technical Note. 61
27251374 2016
386
Functional facial and tongue movement disorders. 61
27719855 2016
387
Does arteriosclerosis contribute to hemifacial spasm? 61
26545931 2016
388
Coexistence of ocular neuromyotonia and hemifacial spasm. 61
26810424 2016
389
Microvascular Decompression Surgery for Hemifacial Spasm. 61
26703065 2016
390
Is hypertension a risk factor of hemifacial spasm? 61
26969561 2016
391
[Trigeminal neuralgia and hemifacial spasm associated with vertebrobasilar artery tortuosity]. 61
27029331 2016
392
[Tinnitus in patients with hemifacial spasm: a treatable combination?] 61
27781964 2016
393
Clinical differences between botulinum neurotoxin type A and B. 61
26260691 2015
394
Management of Geniculate Ganglion Hemangiomas: Case Series and Systematic Review of the Literature. 61
26536415 2015
395
Hypertension of neurogenic origin: effect of microvascular decompression of the CN IX-X root entry/exit zone and ventrolateral medulla on blood pressure in a prospective series of 48 patients with hemifacial spasm associated with essential hypertension. 61
26230479 2015
396
Hemifacial spasm due to vertebrobasilar dolichoectasia: a case report. 61
26649123 2015
397
Microvascular decompression and MRI findings in trigeminal neuralgia and hemifacial spasm. A single center experience. 61
26519891 2015
398
A Case of Facial Spasm Associated with Ipsilateral Cerebellopontine Angle Arachnoid Cyst. 61
28824969 2015
399
The Incidence of Early Postoperative Conductive Hearing Loss after Microvascular Decompression of Hemifacial Spasm. 61
26682118 2015
400
The Difference of Treatment Results between Botulinum Toxin A Split Injection Sites and Botulinum Toxin A Non-Split Injection Sites for Hemifacial Spasm. 61
26817183 2015
401
Fluid structure interaction analysis reveals facial nerve palsy caused by vertebral-posterior inferior cerebellar artery aneurysm. 61
26453756 2015
402
Management of vessels passing through the facial nerve in the treatment of hemifacial spasm. 61
26329733 2015
403
Hemifacial spasm caused by a cerebellopontine angle arachnoid cyst. Case report and literature review. 61
26165486 2015
404
[The interest of electroneuromyography in peripheral facial palsy]. 61
26250881 2015
405
Exposure of Titanium Mesh after Cranioplasty for Microvascular Decompression Surgery: Two Case Reports. 61
28663983 2015
406
Microvascular Decompression for Hemifacial Spasm Associated with Bilateral Vertebral Artery Compression. 61
26102619 2015
407
Reduction in high-frequency hearing loss following technical modifications to microvascular decompression for hemifacial spasm. 61
26162037 2015
408
Facial Weakness, Otalgia, and Hemifacial Spasm: A Novel Neurological Syndrome in a Case-Series of 3 Patients With Rheumatic Disease. 61
26447997 2015
409
Quantitative Study of Posterior Fossa Crowdedness in Hemifacial Spasm. 61
26341431 2015
410
Free-running EMG monitoring during microvascular decompression for hemifacial spasm. 61
26143309 2015
411
Hemifacial spasm and postural abnormalities; clinical and posturographical analyses. 61
25228403 2015
412
Hemifacial spasm: The past, present and future. 61
26111430 2015
413
Intra-operative monitoring of two facial muscles in hemifacial spasm surgery. 61
26073921 2015
414
Corneal and Tear Film Changes After Botulinum Toxin-A in Blepharospasm or Hemifacial Spasm. 61
26075455 2015
415
Botulinum toxin injections for the treatment of hemifacial spasm over 16 years. 61
26100157 2015
416
The indications for and the diagnostic yield of imaging in neuro-ophthalmic and orbital disorders. 61
27363961 2015
417
Prevalence and Associated Factors of Neurovascular Contact in Patients With Hemifacial Spasm. 61
26176193 2015
418
Residual hemifacial spasm after microvascular decompression: prognostic factors with emphasis on preoperative psychological state. 61
25869929 2015
419
Is hemifacial spasm a phenomenon of the central nervous system? --The role of desflurane on the lateral spread response. 61
25454282 2015
420
Canine hemifacial spasm: a misnomer? 61
26046370 2015
421
Real-time Monitoring of the Lateral Spread Response Resulting from Serial Decompression for Hemifacial Spasm Caused by a Fusiform Aneurysm. 61
26140340 2015
422
Supine No-Retractor Method in Microvascular Decompression for Hemifacial Spasm: Results of 100 Consecutive Operations. 61
26225302 2015
423
Microvascular decompression for hemifacial spasm: how can we protect auditory function? 61
25665598 2015
424
Lateral basal approach with a supine, no-retractor method for microvascular decompression for hemifacial spasm. 61
25791694 2015
425
Two Cases of Secondary Hemifacial Spasm: Pathophysiology and Management. 61
26090083 2015
426
Hemifacial spasm associated with the vertebral artery fenestration. 61
26053826 2015
427
Hearing outcomes after loss of brainstem auditory evoked potentials during microvascular decompression. 61
25656003 2015
428
MRI findings in patients with a history of failed prior microvascular decompression for hemifacial spasm: how to image and where to look. 61
25430858 2015
429
Immediate disappearance of hemifacial spasm after partial removal of ponto-medullary junction anaplastic astrocytoma: case report. 61
25382264 2015
430
Characteristic anatomical conformation of the vertebral artery causing vascular compression against the root exit zone of the facial nerve in patients with hemifacial spasm. 61
25585837 2015
431
Levodopa-responsive hemiparkinsonism secondary to cystic expansion from a coiled cerebral aneurysm. 61
24707971 2015
432
Botulinum toxin and blink rate in patients with blepharospasm and increased blinking. 61
24963123 2015
433
Structural changes in the CNS of patients with hemifacial spasm. 61
25595976 2015
434
Bilateral hemifacial spasm might be cured by unilateral microvascular decompression. 61
25597484 2015
435
Delayed relief of hemifacial spasm after microvascular decompression. 61
25668113 2015
436
Microvascular decompression for hemifacial spasm: 3-dimensional operative video. 61
25255262 2015
437
Advances in microvascular decompression for hemifacial spasm. 61
29937774 2015
438
Spread of Muscle Spasms in Hemifacial Spasm. 61
30363856 2015
439
A case of hemifacial spasm caused by an artery passing through the facial nerve. 61
25810866 2015
440
Absence of bacterial or fungal growth in vials of reconstituted botulinum toxin type A after storage. 61
25717119 2015
441
Switch from abobotulinumtoxinA (Dysport®) to incobotulinumtoxinA (Xeomin®) botulinum toxin formulation: a review of 257 cases. 61
25325305 2015
442
Usefulness of subtraction of 3D T2WI-DRIVE from contrast-enhanced 3D T1WI: preoperative evaluations of the neurovascular anatomy of patients with neurovascular compression syndrome. 61
25300986 2015
443
Preoperative MRI in neurovascular compression syndromes and its role for microsurgical considerations. 61
25524482 2015
444
An unusual cause of hemifacial spasm. 61
25058594 2015
445
The mechanism of hemifacial spasm: a new understanding of the offending artery. 61
25034027 2015
446
Hemifacial spasm caused by an aberrant jugular branch of the ascending pharyngeal artery. 61
25232808 2015
447
Microvascular decompression under neuroendoscopic view in hemifacial spasm: rostral-type compression and perforator-type compression. 61
25502988 2015
448
Cerebellar retraction and hearing loss after microvascular decompression for hemifacial spasm. 61
25514867 2015
449
Evaluation of concentrations of botulinum toxin A for the treatment of hemifacial spasm: a randomized double-blind crossover trial. 61
25730053 2015
450
Recognizing uncommon presentations of psychogenic (functional) movement disorders. 61
25667816 2015
451
Effects of parasagittal meningiomas on intracranial venous circulation assessed by the virtual reality technology. 61
26550184 2015
452
Trigeminal neuralgia in a patient with Marfan syndrome: case report. 61
24390183 2015
453
Indications and Timings of Re-operation for Residual or Recurrent Hemifacial Spasm after Microvascular Decompression: Personal Experience and Literature Review. 61
26226977 2015
454
Clinical and electrophysiological studies of botulinum toxin type A to treat hemifacial spasm complicated with auricular symptoms. 61
26309655 2015
455
Microvascular decompression for hemifacial spasm secondary to vertebrobasilar dolichoectasia: surgical strategies, technical nuances and clinical outcomes. 61
25510536 2015
456
Altered spontaneous brain activity in patients with hemifacial spasm: a resting-state functional MRI study. 61
25603126 2015
457
[Pre-surgical simulation of microvascular decompression for hemifacial spasm using 3D-models]. 61
25557098 2015
458
Delayed relief of hemifacial spasm after microvascular decompression: can it be avoided? 61
25298013 2015
459
Systematic Literature Review of AbobotulinumtoxinA in Clinical Trials for Blepharospasm and Hemifacial Spasm. 61
26566457 2015
460
CPAP Therapy Improves Intractable Hemifacial Spasm. 61
26550503 2015
461
Hemifacial spasm: 20-year surgical experience, lesson learned. 61
26015871 2015
462
Clinical impact of residual lateral spread response after adequate microvascular decompression for hemifacial spasm: A retrospective analysis. 61
26098605 2015
463
Long-term therapy of benign essential blepharospasm and facial hemispasm with botulinum toxin A: retrospective assessment of the clinical and quality of life impact in patients treated for more than 15 years. 61
24604684 2014
464
Complications of botulinum toxin application: differences between hemifacial spasm and post-facial palsy synkinesis. 61
24647748 2014
465
Microvascular decompression surgery: surgical principles and technical nuances based on 4000 cases. 61
24597913 2014
466
Scientific skepticism and new discoveries: an analysis of a report of zinc/phytase supplementation and the efficacy of botulinum toxins in treating cosmetic facial rhytides, hemifacial spasm and benign essential blepharospasm. 61
25105993 2014
467
Appropriate time to establish baseline responses for brain stem auditory evoked potentials during microvascular decompression for hemifacial spasm. 61
25271691 2014
468
Safety of onabotulinum toxin a injection to the central upper eyelid and eyebrow regions. 61
24777259 2014
469
Analysis of therapeutic effect of microvascular decompression surgery on idiopathic hemifacial spasm. 61
25119413 2014
470
Thin-slice T2 MRI imaging predicts vascular pathology in hemifacial spasm: a case-control study. 61
25044001 2014
471
Active role of cerebellar flocculus in hemifacial spasm: case report. 61
23824050 2014
472
Facial dystonias and rosacea: is there an association? 61
24831933 2014
473
Hemibody pain relieved by microvascular decompression of the contralateral caudal medulla: case report. 61
24769190 2014
474
Intraoperative indocyanine green angiography during microvascular decompression surgery: report of 30 cases. 61
24809529 2014
475
Lipoma causing glossopharyngeal neuralgia: a case report and review of literature. 61
25328654 2014
476
Adverse events associated with botulinum toxin injection: a multidepartment, retrospective study of 5310 treatments administered to 1819 patients. 61
23537074 2014
477
Delayed dural arteriovenous fistula after microvascular decompression for hemifacial spasm. 61
25328659 2014
478
Is hemifacial spasm accompanied by hemodynamic changes detectable by ultrasound? 61
24915902 2014
479
Cholesteatoma of cerebellopontine angle presented as trigeminal neuralgia. 61
24914757 2014
480
Etiology, diagnosis, and management of facial palsy: 2000 patients at a facial nerve center. 61
24431233 2014
481
Intermediate nerve neuralgia can be diagnosed and cured by microvascular decompression. 61
25006894 2014
482
Hemifacial spasm and trigeminal neuralgia in Chiari's I malformation with hydrocephalus: case report and literature review. 61
24908219 2014
483
Upregulation of Nav1.8 in demyelinated facial nerves might be relevant to the generation of hemifacial spasm. 61
24892416 2014
484
Relation between the persistence of an abnormal muscle response and the long-term clinical course after microvascular decompression for hemifacial spasm. 61
24305017 2014
485
Brainstem auditory evoked potential monitoring and neuro-endoscopy: two tools to ensure hearing preservation and surgical success during microvascular decompression. 61
24768092 2014
486
Microvascular decompression in patients with coexistent trigeminal neuralgia, hemifacial spasm and glossopharyngeal neuralgia. 61
24604137 2014
487
The significance of intraoperative electromyographic "lateral spread" in predicting outcome of microvascular decompression for hemifacial spasm. 61
25072013 2014
488
Combined intraoperative monitoring of abnormal muscle response and Z-L response for hemifacial spasm with tandem compression type. 61
24510052 2014
489
The strategy of microvascular decompression for hemifacial spasm: how to decide the endpoint of an MVD surgery. 61
24647657 2014
490
Factors affecting final facial nerve outcome following vestibular schwannoma surgery. 61
24685071 2014
491
A successful treatment of coexistent hemifacial spasm and trigeminal neuralgia caused by a huge cerebral arteriovenous malformation: a case report. 61
24657981 2014
492
Psychiatric disorders in idiopathic-isolated focal dystonia. 61
24449065 2014
493
Analysis of wave III of brain stem auditory evoked potential waveforms during microvascular decompression of cranial nerve VII for hemifacial spasm. 61
24691229 2014
494
Spectrum and burden of movement disorder conditions in a tertiary movement disorders centre--a 10-year trend. 61
24833071 2014
495
Continuous intraoperative monitoring of abnormal muscle response in microvascular decompression for hemifacial spasm; a real-time navigator for complete relief. 61
24272304 2014
496
Resolution of hemifacial spasm after successful treatment of posterior fossa arteriovenous malformation by gamma knife radiosurgery. 61
24635940 2014
497
'Twenty-four-and-a-half' syndrome and contralateral hemifacial spasm due to pontine carvernoma. 61
24759363 2014
498
Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm. 61
23844601 2014
499
Emprical factors associated with Brainstem auditory evoked potential monitoring during microvascular decompression for hemifacial spasm and its correlation to hearing loss. 61
24306235 2014
500
[Changes in dose and injection pattern in the botulinum toxin long-term therapy of facial dyskinesis]. 61
24323508 2014
501
Facial nerve compression by the posterior inferior cerebellar artery causing facial pain and swelling: a case report. 61
24661509 2014
502
Preoperative assessment of hemifacial spasm by the coronal heavily T2-weighted MR cisternography. 61
24249670 2014
503
Facial Motor Neuron Excitability in Hemifacial Spasm: A Facial MEP Study. 61
24534037 2014
504
[Microneurosurgery for the trigeminal neuralgia and hemifacial spasm and glosspharyngeal neuralgia with endoscopic]. 61
25185291 2014
505
Adolescent-onset idiopathic hemifacial spasm. 61
24823728 2014
506
Is hemifacial spasm of peripheral or central origin? 61
24534022 2014
507
Value-based neurosurgery: the example of microvascular decompression surgery. 61
24286152 2014
508
Evidence of ancillary trigeminal innervation of levator palpebrae in the general population. 61
24120706 2014
509
[Hemifacial spasm due to temporal bone cholesterol granuloma]. 61
24469941 2014
510
Misdiagnosis of hemifacial spasm is a frequent event in the primary care setting. 61
24604365 2014
511
Brissaud-Sicard syndrome caused by a diffuse brainstem glioma. A rare differential diagnosis of hemifacial spasm. 61
24384991 2014
512
Lateral spread response monitoring during microvascular decompression for hemifacial spasm. Comparison of two targets of partial neuromuscular blockade. 61
24499959 2014
513
[Vascular compression syndromes: our 24 year endoscope-assisted microvascular decompression experiences]. 61
24798433 2014
514
Presurgical evaluation of hemifacial spasm and spasmodic torticollis caused by a neurovascular conflict from AICA with 3T MRI integrated by 3D drive and 3D TOF image fusion: A case report and review of the literature. 61
25101203 2014
515
Hemifacial spasm caused by the cross-compression of the vertebral artery loop--a case-centered report of a stitched sling retraction technique. 61
25571674 2014
516
Arterial compression of nerve is the primary cause of trigeminal neuralgia. 61
23963805 2014
517
Small volume of the posterior cranial fossa and arterial hypertension are risk factors of hemifacial spasm. 61
25482247 2014
518
Clinical features and treatment status of hemifacial spasm in China. 61
24571874 2014
519
Hemifacial spasm and neurovascular compression. 61
25405219 2014
520
[Migraine-triggered hemifacial spasm: another case study]. 61
22884700 2014
521
Determination of the keyhole position in a lateral suboccipital retrosigmoid approach. 61
24201103 2014
522
Hemifacial spasm revealing contralateral peripheral facial palsy. 61
24120245 2013
523
Electrophysiologic investigation during facial motor neuron suppression in patients with hemifacial spasm: possible pathophysiology of hemifacial spasm: a pilot study. 61
24466519 2013
524
[Guiding values of facial nerve 3D-TOF-MRA and 3D-FIESTA scan for primary hemifacial spasm operation]. 61
24534314 2013
525
Efficacy of botulinum toxin A for treatment of unilateral spasms of the eyelid and its prognosis. 61
24254570 2013
526
Microvascular decompression for hemifacial spasm in patients >65 years of age: an analysis of outcomes and complications. 61
24000070 2013
527
Teaching neuroimages: microvascular decompression of the optic nerve. 61
24166969 2013
528
Importance of awareness of the rhomboid lip in microvascular decompression surgery for hemifacial spasm. 61
23706056 2013
529
Hemifacial spasm and jugular foramen syndrome caused by diametrically opposite aneurysms on the vertebral artery. 61
23266867 2013
530
Insight into the frequent occurrence of dura mater graft-associated Creutzfeldt-Jakob disease in Japan. 61
23595947 2013
531
Microvascular decompression for hemifacial spasm: focus on late reoperation. 61
23749049 2013
532
Microvascular decompression for neurovascular conflicts in the cerebello-pontine angle: which role for endoscopy? 61
23884611 2013
533
Advanced virtual magnetic resonance imaging (MRI) techniques in neurovascular conflict: bidimensional image fusion and virtual cisternography. 61
23716284 2013
534
Clinical review of the effects of hominis placental pharmacopuncture in the treatment of facial spasm patients. 61
25780676 2013
535
A new possible mechanism of hearing loss after microvascular decompression for hemifacial spasm. 61
23942352 2013
536
A recommendation on the basis of long-term follow-up results of our microvascular decompression operation for hemifacial spasm. 61
23619960 2013
537
Closed-suction drainage and cerebrospinal fluid leakage following microvascular decompression : a retrospective comparison study. 61
24175025 2013
538
Teaching NeuroImages: concurrent hemifacial spasm and trigeminal neuralgia due to vertebrobasilar dolichoectasia. 61
23960199 2013
539
Complementary therapies in hemifacial spasm and comparison with other movement disorders. 61
23869681 2013
540
The Babinski-2 sign in hemifacial spasm. 61
23637014 2013
541
Conversion ratio between Dysport and Botox in clinical practice: an overview of available evidence. 61
23576131 2013
542
Tracking the source of cerebellar epilepsy: hemifacial seizures associated with cerebellar cortical dysplasia. 61
23375885 2013
543
Value of 3-dimensional high-resolution magnetic resonance imaging in detecting the offending vessel in hemifacial spasm: comparison with intraoperative high definition endoscopic visualization. 61
23695647 2013
544
Dysport (botulinum toxin type A) in routine therapeutic usage: a telephone needs assessment survey of European physicians to evaluate current awareness and adherence to product labeling changes. 61
23783005 2013
545
Intralabyrinthine schwannomas: a case series with discussion of the diagnosis and management. 61
23598704 2013
546
Long-term botulinum toxin treatment of benign essential blepharospasm, hemifacial spasm, and Meige syndrome. 61
23541393 2013
547
Atypical hemifacial spasm due to vertebral artery dolichoectasia: rare cause of a rarer clinical entity. 61
23845680 2013
548
Hemifacial spasm developing after the adhesion of the facial nerve and vertebral artery. 61
23574687 2013
549
Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders. 61
23380701 2013
550
Delayed Unilateral Soft Palate Palsy without Vocal Cord Involvement after Microvascular Decompression for Hemifacial Spasm. 61
24003372 2013
551
Gamma knife radiosurgery for large vestibular schwannomas: a Canadian experience. 61
23603169 2013
552
Microvascular decompression for the patient with painful tic convulsif after Bell palsy. 61
23714994 2013
553
'Is tinnitus accompanied by hemifacial spasm in normal-hearing patients also a type of hyperactive neurovascular compression syndrome? : A magnetoencephalography study. 61
23651913 2013
554
The role of vein in microvascular decompression for hemifacial spasm: a clinical analysis of 15 cases. 61
23540407 2013
555
Use of fillers as adjunct therapy for the treatment of lower face hemifacial spasm. 61
23559346 2013
556
Microvascular decompression of the root emerging zone for hemifacial spasm: evaluation by fusion magnetic resonance imaging and technical considerations. 61
23494136 2013
557
[AICA anatomic variation as a factor of worse prognosis for the surgical treatment of hemi-facial spasm]. 61
23815844 2013
558
Movement disorders in multiple sclerosis and other demyelinating diseases. 61
23522528 2013
559
Headache in hemifacial spasm patients. 61
23311349 2013
560
Surgical treatment of hemifacial spasm with zone-4 offending vessel. 61
23355064 2013
561
Microvascular decompression for hemifacial spasm associated with the vertebral artery. 61
23053242 2013
562
Sensory tricks in focal dystonia and hemifacial spasm. 61
23216586 2013
563
Hemifacial spasm leading to diagnosis of Moyamoya disease. 61
23793182 2013
564
Blepharospasm and hemifacial spasm: long-term treatment with botulinum toxin. 61
22652139 2013
565
Developmental venous anomaly responsible for hemifacial spasm. 61
23859243 2013
566
Incidence of high-frequency hearing loss after microvascular decompression for hemifacial spasm. 61
23394342 2013
567
Microvascular decompression for hemifacial spasm: long-term outcome and prognostic factors, with emphasis on delayed cure. 61
22940822 2013
568
Effect of previous botulinum neurotoxin treatment on microvascular decompression for hemifacial spasm. 61
23452316 2013
569
[Hemifacial spasm caused by a dissecting aneurysm of the vertebral artery, and resulting in acute exacerbation]. 61
23459522 2013
570
Analysis of interpeak latencies of brainstem auditory evoked potential waveforms during microvascular decompression of cranial nerve VII for hemifacial spasm. 61
23451756 2013
571
[Safety and efficacy of botulinum toxin in hemifacial spasm]. 61
23270989 2013
572
Microvascular decompression treatment for post-Bell's palsy hemifacial spasm. 61
23336178 2013
573
An evidence-based review of botulinum toxin (Botox) applications in non-cosmetic head and neck conditions. 61
23476731 2013
574
Functional end-plate recovery in long-term botulinum toxin therapy of hemifacial spasm: a nerve conduction study. 61
22367224 2013
575
Surgical results of microvascular decompression procedures and patient's postoperative quality of life: review of 139 cases. 61
23803613 2013
576
A single microvascular decompression surgery cures a patient with trigeminal neuralgia, hemifacial spasm, tinnitus, hypertension, and paroxysmal supraventricular tachycardia caused by the compression of a vertebral artery. 61
23466845 2013
577
Microvascular decompression for familial hemifacial spasm : single institute experience. 61
23440303 2013
578
Intractable hemifacial spasm treated by pulsed radiofrequency treatment. 61
23342210 2013
579
Botulinum toxin in hemifacial spasm: Revisited. 61
23960334 2013
580
Facial nerve palsy and hemifacial spasm. 61
23931790 2013
581
Hemifacial spasm and recurrent stroke due to vertebrobasilar dolichoectasia coexisting with saccular aneurysm of the basilar artery: a case report. 61
23546920 2013
582
Microvascular decompression for hemifacial spasm due to four offending vessels: a case report. 61
23546911 2013
583
Differentiating non-motor symptoms in Parkinson's disease from controls and hemifacial spasm. 61
23408927 2013
584
Safety and effectiveness of microvascular decompression for the treatment of hemifacial spasm in the elderly. 61
23921578 2013
585
Intermittent hypoglossal nerve palsy caused by a calcified persistent hypoglossal artery: an uncommon neurovascular compression syndrome. 61
23020989 2012
586
A comparison of facial muscle squeezing versus non-facial muscle squeezing on the efficacy of botulinumtoxin-A injections for the treatment of facial dystonia. 61
23061606 2012
587
Efficacy of carbamazepine combined with botulinum toxin a in the treatment of blepharospasm and hemifacial spasm. 61
23225838 2012
588
Gamma Knife surgery for hemifacial spasm related to cerebellopontine angle tumors. 61
23205806 2012
589
Dural arteriovenous fistula involving an isolated sinus treated using transarterial onyx embolization. 61
23323170 2012
590
Crotoxin in humans: analysis of the effects on extraocular and facial muscles. 61
23715138 2012
591
Efficacy of the Disappearance of Lateral Spread Response before and after Microvascular Decompression for Predicting the Long-Term Results of Hemifacial Spasm Over Two Years. 61
23133727 2012
592
Drainage Pathway of the Superior Petrosal Vein Evaluated by CT Venography in Petroclival Meningioma Surgery. 61
24083122 2012
593
Hemifacial spasm: conservative and surgical treatment options. 61
23264807 2012
594
The representation of movement disorders in fictional literature. 61
22752692 2012
595
Delayed cranial nerve palsy after microvascular decompression for hemifacial spasm. 61
23133714 2012
596
An easy adjustable method of ectatic vertebrobasilar artery transposition for microvascular decompression. 61
22390889 2012
597
Interactive virtual simulation using a 3D computer graphics model for microvascular decompression surgery. 61
22746377 2012
598
A comparison of three induction regimens using succinylcholine, vecuronium, or no muscle relaxant: impact on the intraoperative monitoring of the lateral spread response in hemifacial spasm surgery: study protocol for a randomised controlled trial. 61
22958580 2012
599
A clinical analysis on microvascular decompression surgery in a series of 3000 cases. 61
22310997 2012
600
Epidermoid cyst causing hemifacial spasm epidermoid cyst in cerebellopontine angle presenting with hemifacial spasm. 61
23188990 2012
601
Microvascular decompression for hemifacial spasm. 61
22948645 2012
602
A "sling swing transposition" technique with pedicled dural flap for microvascular decompression in hemifacial spasm. 61
22186845 2012
603
Delayed recurrence of hemifacial spasm after successful microvascular decompression: follow-up results at least 5 years after surgery. 61
22843173 2012
604
The role of autonomic nervous system in the pathophysiology of hemifacial spasm. 61
22663936 2012
605
Microvascular decompression for hemifacial spasm: technical notes on pontomedullary sulcus decompression. 61
22627673 2012
606
Single-fraction radiosurgery for presumed intracranial meningiomas: efficacy and complications from a 22-year experience. 61
22209154 2012
607
Botulinum toxin for the treatment of movement disorders. 61
22661378 2012
608
High-resolution 3D-constructive interference in steady-state MR imaging and 3D time-of-flight MR angiography in neurovascular compression: a comparison between 3T and 1.5T. 61
22403774 2012
609
Botulinum toxin in hemifacial spasm: the challenge to assess the effect of treatment. 61
22231846 2012
610
Safety and effectiveness of microvascular decompression for treatment of hemifacial spasm: a systematic review. 61
22168965 2012
611
The effect of microvascular decompression for hemifacial spasm caused by vertebrobasilar dolichoectasia. 61
23091664 2012
612
Neonatal hemifacial spasm and fourth ventricle mass. 61
22548445 2012
613
Hemifacial spasm: clinical characteristics of 321 Indian patients. 61
22222858 2012
614
Hemifacial spasm, vertebrobasilar dolichoectasia and neurofibromatosis type 1. 61
22480682 2012
615
Hearing outcomes following microvascular decompression for hemifacial spasm. 61
22410649 2012
616
Surgical treatment for combined hemifacial spasm and atypical trigeminal neuralgia caused by a tortuous basilar artery. Case report and review of the literature. 61
22617178 2012
617
From ritual sword duel to electrophysiology: hyperactive facial motor nucleus in hemifacial spasm. 61
22499336 2012
618
[Treatment of blepharospasm, hemifacial spasm and facial synkinesis with botulinum toxin]. 61
22669435 2012
619
Arachnoid cyst associated with painful tic convulsif. 61
22321360 2012
620
Discovery of a new waveform for intraoperative monitoring of hemifacial spasms. 61
22354720 2012
621
A proposal for standardized analysis of the results of microvascular decompression for trigeminal neuralgia and hemifacial spasm. 61
22327325 2012
622
Sympathetic nerves bridge the cross-transmission in hemifacial spasm. 61
22531749 2012
623
Effect of dietary zinc and phytase supplementation on botulinum toxin treatments. 61
22453589 2012
624
Retrospective evaluation of the dose equivalence of Botox(®) and Dysport (®) in the management of blepharospasm and hemifacial spasm: a novel paradigm for a never ending story. 61
21710123 2012
625
Predicting nonauditory adverse radiation effects following radiosurgery for vestibular schwannoma: a volume and dosimetric analysis. 61
21531086 2012
626
Glucose hypermetabolism in the thalamus of patients with hemifacial spasm. 61
22344604 2012
627
Hemifacial spasm caused by intra-axial brainstem cavernous angioma with venous angiomas. 61
22026472 2012
628
Quality of life in hemifacial spasm patient after treatment with botulinum toxin A; a 24-week, double-blind, randomized, cross-over comparison of Dysport and Neuronox study. 61
22619887 2012
629
Five-year experience with incobotulinumtoxinA (Xeomin(®) ): the first botulinum toxin drug free of complexing proteins. 61
22035051 2012
630
Assessment of non-motor hearing symptoms in hemifacial spasm using magnetoencephalography. 61
22116454 2012
631
Role of arterioles in management of microvascular decompression in patients with hemifacial spasm. 61
22277558 2012
632
Endovascular treatment of hemifacial spasm associated with a petrosal DAVF using transarterial Onyx embolization. A case report. 61
22440603 2012
633
Outcomes of surgical treatment for hemifacial spasm associated with the vertebral artery: severity of compression, indentation, and color change. 61
22160400 2012
634
Factors affecting the quality of life in hemifacial spasm patients. 61
22581593 2012
635
[Persistent labial edema secondary to hemifacial spasm]. 61
21798489 2012
636
Migraine-triggered hemifacial spasm: three new cases. 61
22421902 2012
637
Focal deformity of the cranial nerves observed on multislice motion-sensitized driven equilibrium (MSDE) in patients with neurovascular compression. 61
22261781 2012
638
Hemifacial Spasm due to Compression of the Posterior Inferior Cerebellar Artery Aneurysm Treated with Botulinum Toxin Type-A: A Case Report. 61
22934205 2012
639
Intraoperative facial electromyography and brainstem auditory evoked potential findings in microvascular decompression for hemifacial spasm: correlation with postoperative delayed facial palsy. 61
22777492 2012
640
Using the new clinical grading scale for quantification of the severity of hemifacial spasm: correlations with a quality of life scale. 61
22189960 2012
641
[Endoscopic assistance in microvascular decompression of cranial nerves]. 61
22708429 2012
642
Hemifacial spasm, glossodynia, and dolichoectasia of the basilar artery. 61
20833080 2012
643
Intra-operative neurophysiology during microvascular decompression for hemifacial spasm. 61
22136736 2012
644
Hemifacial spasm developed after contralateral vertebral artery ligation. 61
22396847 2012
645
Prognostic value of intra-operative abnormal muscle response monitoring during microvascular decompression for long-term outcome of hemifacial spasm. 61
22136732 2012
646
The influence of botulinum toxin on auditory disturbances in hemifacial spasm. 61
22426760 2012
647
Obsessive-compulsive-spectrum symptoms in patients with focal dystonia, hemifacial spasm, and healthy subjects. 61
22450617 2012
648
Monitoring of abnormal muscle response and facial motor evoked potential during microvascular decompression for hemifacial spasm. 61
23226604 2012
649
Cranial nerve vascular compression syndromes of the trigeminal, facial and vago-glossopharyngeal nerves: comparative anatomical study of the central myelin portion and transitional zone; correlations with incidences of corresponding hyperactive dysfunctional syndromes. 61
21947457 2011
650
Microvascular decompression surgery for trigeminal neuralgia and hemifacial spasm: naunces of the technique based on experiences with 100 patients and review of the literature. 61
21752534 2011
651
A painful tic convulsif due to double neurovascular impingement. 61
21814746 2011
652
Hemifacial spasm can be the presenting symptom of a fourth ventricle tumour. A short case-illustrated review and pathogenetic considerations. 61
21887494 2011
653
[Ocular wavefront aberrations in patients with facial dystonia treated with botulinum toxin]. 61
22331113 2011
654
Factors associated with quality of life in hemifacial spasm and blepharospasm during long-term treatment with botulinum toxin. 61
21431990 2011
655
[A case of hemifacial spasm in a juglar foramen tumor patient treated by microvascular decompression]. 61
22036823 2011
656
[Clinical efficacy of microvascular decompression plus intraoperative monitoring of abnormal muscle response in the treatment of hemifacial spasm]. 61
22333614 2011
657
Hemifacial spasm caused by cross type vascular compression. 61
22080999 2011
658
Hemifacial spasm associated with intraparenchymal brain stem tumor. 61
22109850 2011
659
Parry-Romberg syndrome combined with hemifacial spasm: association or chance event? 61
22134291 2011
660
Cerebellopontine angle endodermal cyst presenting with hemifacial spasm. 61
21643804 2011
661
Obsessive-compulsive symptoms in primary focal dystonia: a controlled study. 61
21830232 2011
662
Effect of botulinum neurotoxin treatment in the lateral spread monitoring of microvascular decompression for hemifacial spasm. 61
21826681 2011
663
Causes for treatment delays in dystonia and hemifacial spasm: a Canadian survey. 61
21856572 2011
664
Hemifacial spasm due to contralateral aneurysmal compression of the facial nerve successfully treated with endovascular coil embolization: case report. 61
21832966 2011
665
Obsessive-compulsive symptoms among patients with blepharospasm and hemifacial spasm. 61
21762995 2011
666
[Operative neurosurgery: personal view and historical backgrounds (8) suboccipital craniotomy-sitting position-linear incision]. 61
21799230 2011
667
The many faces of hemifacial spasm: differential diagnosis of unilateral facial spasms. 61
21469208 2011
668
Safety study of transcutaneous focused ultrasound for non-invasive skin tightening in Asians. 61
21674541 2011
669
[Clinical application of botulinum toxin]. 61
21747149 2011
670
[Use of botulinum neurotoxin therapy]. 61
21747148 2011
671
Stitched sling retraction technique for microvascular decompression: procedures and techniques based on an anatomical viewpoint. 61
21347661 2011
672
Intraoperative and anatomical descriptions of intracranial connections between the glossopharyngeal and vagus nerves: clinical implications. 61
21395388 2011
673
Dolichoectasia of the intracranial arteries. 61
21404000 2011
674
"Double-stick tape" technique for transposition of an offending vessel in microvascular decompression: technical case report. 61
21389896 2011
675
Vertebral artery pexy for microvascular decompression of the facial nerve in the treatment of hemifacial spasm. 61
21275561 2011
676
[Hemifacial spasm or facial hemispasm?]. 61
21474156 2011
677
Botulinum toxin A (Dysport®): in dystonias and focal spasticity. 61
21668041 2011
678
Surgical treatment of pediatric hemifacial spasm patients. 61
21298452 2011
679
The patterns and risk factors of hearing loss following microvascular decompression for hemifacial spasm. 61
21240531 2011
680
[Adjunctive use of endoscopy during microvascular decompression in the cerebellopontine angle: 27 case reports]. 61
21530987 2011
681
Microvascular decompressions in patients with coexistent hemifacial spasm and trigeminal neuralgia. 61
21221033 2011
682
Correlation between idiopathic hemifacial spasm and the MRI characteristics of the vertebral artery. 61
21316241 2011
683
Enterogenous cyst as a rare cause of hemifacial spasm. 61
21334209 2011
684
Microvascular decompression for hemifacial spasm: evaluating outcome prognosticators including the value of intraoperative lateral spread response monitoring and clinical characteristics in 293 patients. 61
21221005 2011
685
Modulating neuromuscular junction density changes in botulinum toxin-treated orbicularis oculi muscle. 61
21087967 2011
686
Medical waiver for flying after microvascular decompression for hemifacial spasm. 61
21329030 2011
687
Tremor in hemifacial spasm patients. 61
21161713 2011
688
Is it always necessary to apply botulinum toxin into the lower facial muscles in hemifacial spasm?: a randomized, single-blind, crossover trial. 61
21502764 2011
689
Review and update of involuntary facial movement disorders presenting in the ophthalmological setting. 61
21093885 2011
690
[Neurologic indications of botulin in adults]. 61
22238918 2011
691
[Applications of botulin]. 61
22238921 2011
692
PICA origin aneurysm diagnosed 27 years after microvascular decompression of cranial nerve VII. 61
19555405 2011
693
[Vascular compression syndromes of the cranial nerves]. 61
21428033 2011
694
Painful tic convulsif syndrome due to vertebrobasilar dolichoectasia. 61
21716837 2011
695
Hemifacial spasm. 61
21496615 2011
696
Is entire nerve root decompression necessary for hemifacial spasm? 61
21184849 2011
697
Neurological picture. Hemifacial spasm in antique sculpture: interest in the 'other Babinski sign'. 61
20601668 2011
698
The value of abnormal muscle response monitoring during microvascular decompression surgery for hemifacial spasm. 61
21396488 2011
699
Comparison of two different formulations of botulinum toxin A for the treatment of blepharospasm and hemifacial spasm. 61
22194126 2011
700
Hemifacial spasm as a manifestation of pilocytic astrocytoma in a pediatric patient. 61
21977096 2011
701
Botulinum toxin in facial rejuvenation: an update. 61
21093750 2010
702
The potential value of the disappearance of the lateral spread response during microvascular decompression for predicting the clinical outcome of hemifacial spasms: a prospective study. 61
21107188 2010
703
The Potential Value of the Disappearance of the Lateral Spread Response During Microvascular Decompression for Predicting the Clinical Outcome of Hemifacial Spasms: A Prospective Study. 61
27759660 2010
704
Hemifacial spasm as a feature of Chiari malformation: case report. 61
21107151 2010
705
Microneurovascular decompression in patients with hemifacial spasm caused by vascular compression of facial nerve at cisternal portion. 61
20953806 2010
706
An analysis of failed microvascular decompression in patients with hemifacial spasm: focused on the early reoperative findings. 61
20949293 2010
707
Re-operation for persistent hemifacial spasm after microvascular decompression with the aid of intraoperative monitoring of abnormal muscle response. 61
20936485 2010
708
Use of botulinum toxin in the neurology clinic. 61
21045798 2010
709
Adhesion of rhomboid lip to lower cranial nerves as special consideration in microvascular decompression for hemifacial spasm: Report of two cases. 61
21170363 2010
710
Cerebellopontine angle tumors causing hemifacial spasm: types, incidence, and mechanism in nine reported cases and literature review. 61
20845049 2010
711
Asian over-representation among patients with hemifacial spasm compared to patients with cranial-cervical dystonia. 61
20864122 2010
712
Evaluating the effects of ice application on patient comfort before and after botulinum toxin type A injections. 61
20973324 2010
713
Frequency of psychiatric disorders in blepharospasm does not differ from hemifacial spasm. 61
26952832 2010
714
Difference in response to botulinum toxin type A treatment between patients with benign essential blepharospasm and hemifacial spasm. 61
20456439 2010
715
Preoperative evaluation of neurovascular relationships for microvascular decompression in the cerebellopontine angle in a virtual reality environment. 61
19852542 2010
716
[Botulinum toxin type A influence on the lacrimal function of patients with facial dystonia]. 61
21225122 2010
717
An update on the neurologic applications of botulinum toxins. 61
20567945 2010
718
Long-term efficacy of botulinum a toxin for blepharospasm and hemifacial spasm. 61
21059510 2010
719
Radiological reasoning: cerebellopontine mass causing hemifacial spasm. 61
20729405 2010
720
Microvascular decompression in the treatment of trigeminal neuralgia caused by vertebrobasilar ectasia. 61
20644418 2010
721
Hemifacial spasm patient with ipsilateral total absence of common carotid artery, vertebral artery and aneurysm of the contralateral internal carotid artery. 61
20473496 2010
722
Botulinum toxin type A in the treatment of hemifacial spasm: an 11-year experience. 61
20730300 2010
723
Esmail Jorjani (1042-1137) and his descriptions of trigeminal neuralgia, hemifacial spasm, and bell's palsy. 61
20644430 2010
724
An ectopic cranial nerve identified during surgery in the posterior fossa for hemifacial spasm: a word of caution. 61
20726758 2010
725
[Botulinum toxin and facial palsy. Our experience]. 61
20400055 2010
726
Hemilingual spasm: defining a new entity, its electrophysiological correlates and surgical treatment through microvascular decompression. 61
20559106 2010
727
The role of the injection botulinum toxin A in cases of blepharospasm syndrome, hemifacial spasm and Meige's syndrome. 61
22610735 2010
728
Reduced facial nerve hyperexcitability from contralateral cerebral stroke in hemifacial spasm. 61
20310047 2010
729
Treatment with botulinum toxin improves the hyperexcitability of the facial motoneuron in patients with hemifacial spasm. 61
19660185 2010
730
Microvascular decompression for treating hemifacial spasm: lessons learned from a prospective study of 1,174 operations. 61
20349099 2010
731
[Long-term results of microvascular decompression in treatment of hemifacial spasm]. 61
21260935 2010
732
Taste sense in patients with hemifacial spasm. 61
20409717 2010
733
Microsurgical treatment for 55 patients with hemifacial spasm due to cerebellopontine angle tumors. 61
20217169 2010
734
[Effects of abnormal muscle response monitoring on manipulation of microvascular decompression]. 61
20543226 2010
735
Endoscopic clipping of a middle cerebral artery aneurysm in a middle fossa arachnoid cyst and review of the literature. 61
20809455 2010
736
Auditory evoked blink reflex and posterior auricular muscle response: observations in patients with HFS and PFS. 61
19767218 2010
737
Delayed Progressive Extradural Pneumatocele due to Incomplete Sealing of Opened Mastoid Air Cell after Micro-Vascular Decompression. 61
20617099 2010
738
[Recognition and management of hidden related vessel during the operation of microvascular decompression for hemifacial spasm]. 61
20979752 2010
739
Hemifacial spasm and reinnervation synkinesias: long-term treatment with either Botox or Dysport. 61
20437061 2010
740
The efficacy and safety of microvascular decompression for hemifacial spasm in elderly patients. 61
20617090 2010
741
Hemifacial spasm non-motor and motor-related symptoms and their response to botulinum toxin therapy. 61
20467763 2010
742
[Study of neurovascular contact in essential hemifacial spasm: an example of CISS sequence and magnetic resonance angiography]. 61
20643038 2010
743
Microvascular decompression in patient with atypical features of hemifacial spasm secondary to compression by a tortuous vertebrobasilar system: case report. 61
20495395 2010
744
Facial nerve motor-evoked potential monitoring during microvascular decompression for hemifacial spasm. 61
19726411 2010
745
Image-guided surgical planning using anatomical landmarks in the retrosigmoid approach. 61
19902141 2010
746
Paroxysmal staccato tinnitus: a carbamazepine responsive hyperactivity dysfunction symptom of the eighth cranial nerve. 61
19778910 2010
747
Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes. 61
19648904 2010
748
An early image of hemifacial spasm: Edouard Brissaud contribution. 61
20175213 2010
749
Osteoma of the internal auditory canal. 61
20822750 2010
750
Psychiatric disorders in adult-onset focal dystonia: a case-control study. 61
20108377 2010
751
Keyhole microsurgery for trigeminal neuralgia, hemifacial spasm and glossopharyngeal neuralgia. 61
19536556 2010
752
New stereoscopic virtual reality system application to cranial nerve microvascular decompression. 61
19997945 2010
753
Role of short-term out patient video electroencephalography in diagnosis of paroxysmal disorders. 61
19962279 2010
754
Complications in retrosigmoid cranial nerve surgery. 61
19593681 2010
755
Familial hemifacial spasm and determinants of late onset. 61
19812891 2010
756
Treatment of idiopathic hemifacial spasm with radiosurgery or hypofractionated stereotactic radiotherapy: preliminary results. 61
20376743 2010
757
Botulinum toxin. 61
20418969 2010
758
Surgical outcome and improvement in quality of life after microvascular decompression for hemifacial spasms: a case series assessment using a validated disease-specific scale. 61
20948243 2010
759
Efficacy of functional training of the facial muscles for treatment of incomplete peripheral facial nerve injury. 61
20936190 2010
760
[Hemifacial spasm]. 61
21322138 2010
761
Prospective, randomized, double-blind study, comparing botulinum toxins type a botox and prosigne for blepharospasm and hemifacial spasm treatment. 61
20124784 2010
762
The effect of bangerter occlusion foils on blepharospasm and hemifacial spasm in occlusion-positive and occlusion-negative patients. 61
20148097 2010
763
Somatosensory temporal discrimination in patients with primary focal dystonia. 61
19541688 2009
764
Routine use of Xeomin in patients previously treated with Botox: long term results. 61
20002739 2009
765
A reappraisal of the value of lateral spread response monitoring in the treatment of hemifacial spasm by microvascular decompression. 61
19546109 2009
766
Validation of a Chinese version of disease specific quality of life scale (HFS-36) for hemifacial spasm in Taiwan. 61
20034399 2009
767
Cerebellopontine angle arachnoid cyst: a case of hemifacial spasm caused by an organic lesion other than neurovascular compression: case report. 61
19934941 2009
768
Otoneurological management of petrous apex cholesterol granuloma. 61
19880030 2009
769
Combined hyperactive dysfunction syndrome of the cranial nerves. 61
19893725 2009
770
Botulinum toxin in facial rejuvenation: an update. 61
19850191 2009
771
Sensitivity of high-resolution three-dimensional magnetic resonance angiography and three-dimensional spoiled-gradient recalled imaging in the prediction of neurovascular compression in patients with hemifacial spasm. 61
19392597 2009
772
Complications of posterior cranial fossa surgery--an institutional experience of 500 patients. 61
19604553 2009
773
Infranuchal infrafloccular approach to the more vulnerable segments of the facial nerve in microvascular decompressions for the hemifacial spasm. 61
19893723 2009
774
Results of auditory brainstem response monitoring of microvascular decompression: a prospective study of 22 patients with hemifacial spasm. 61
19655333 2009
775
[Neurovascular interactions in hemifacial spasm]. 61
20143608 2009
776
Patterns of hearing loss after microvascular decompression for hemifacial spasm. 61
19762909 2009
777
Utility of intraoperative electromyography in microvascular decompression for hemifacial spasm: a meta-analysis. 61
19795949 2009
778
Hemilingual spasm: pathophysiology. 61
19520147 2009
779
Syndrome of fixed dystonia in adolescents--short term outcome in 4 cases. 61
18996036 2009
780
[Bell's palsy: from viral aetiology to diagnostic reality]. 61
19195745 2009
781
Three-dimensional MR volumetric analysis of the posterior fossa CSF space in hemifacial spasm. 61
19786697 2009
782
Hemifacial spasm caused by a huge tentorial meningioma. 61
19844631 2009
783
Microsurgery after radiosurgery or radiotherapy for vestibular schwannomas. 61
19751874 2009
784
Neurovascular compression in painful tic convulsif. 61
19396392 2009
785
[Tiapride with the horn of saiga tatarica in the treatment of hemifacial spasm]. 61
20041610 2009
786
[Botulinum toxin therapy for focal dystonia]. 61
19581172 2009
787
Hemifacial spasm caused by vascular compression of the distal portion of the facial nerve associated with configuration variation of the facial and vestibulocochlear nerve complex. 61
19621293 2009
788
Neutralizing antibodies and secondary therapy failure after treatment with botulinum toxin type A: much ado about nothing? 61
19620852 2009
789
Reversible hemifacial spasm due to neurocysticercosis. 61
20174503 2009
790
Unusual causes and presentations of hemifacial spasm. 61
19574834 2009
791
Idiopathic hemifacial spasm responsive to zonisamide: a case report. 61
19644231 2009
792
Gabapentin responsive audiovestibular paroxysmia. 61
19345961 2009
793
Prognostic factors of hemifacial spasm after microvascular decompression. 61
19609416 2009
794
[Revision surgery of the posterior fossa cranial nerves disease]. 61
19567042 2009
795
[Hemifacial spasm]. 61
19576481 2009
796
[Functional anatomy of the facial nerve]. 61
19298978 2009
797
[Electrophysiological monitoring of cranial motor nerves (V, VII, IX, X, XI, XII)]. 61
19298980 2009
798
Experience with long-term treatment with albumin-supplemented botulinum toxin type A. 61
19319477 2009
799
[Neurosurgical treatment of primary hemifacial spasm with microvascular decompression]. 61
19329131 2009
800
Hemifacial spasm caused by epidermoid tumor at cerebello pontine angle. 61
19352486 2009
801
Parotid tumor presenting with hemifacial spasm. 61
19300162 2009
802
Executive functioning in patients with blepharospasm in comparison with patients with hemifacial spasm. 61
19330202 2009
803
Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasm. 61
19364366 2009
804
Neurophysiological mechanisms of conduction impairment of the auditory nerve during cerebellopontine angle surgery. 61
19109061 2009
805
[Microvascular decompression for the hemifacial spasm with endoscopy]. 61
19452713 2009
806
Intraoperative electrophysiological monitoring in microvascular decompression for hemifacial spasm. 61
19103492 2009
807
Blink reflex recovery in central and peripherally originated movement disorders of the cranio-cervical area: a comparative study. 61
19280796 2009
808
Action-induced hemifacial spasm and its resolution with botulinum toxin. 61
18942081 2009
809
First description of neurogenic sinus bradycardia in idiopathic hemifacial spasm. 61
18207506 2009
810
The effects of botulinum toxin A on ephaptic transmission in idiopathic hemifacial spasm. 61
19863260 2009
811
Hemifacial spasm and pontine compression caused by a giant vertebrobasilar dolichoectasia. 61
19295203 2009
812
[Transposition technique of microvascular decompression for hemifacial spasm without using a brain retractor]. 61
19175031 2009
813
[Use of botulinum neurotoxin for spasticity]. 61
19110753 2008
814
Hemifacial spasm caused by fusiform aneurysm at vertebral artery-posterior inferior cerebellar artery junction. 61
19137088 2008
815
Endoscopic microvascular decompression of the hemifacial spasm. 61
19061769 2008
816
Focal motor seizures mimicking hemifacial spasm. 61
18325823 2008
817
[Ocular dryness in the side that has been infiltrated and not infiltrated with botulinum toxin to treat hemifacial spasm]. 61
19085887 2008
818
Prognostic value of intra-operative lateral spread response monitoring during microvascular decompression in patients with hemifacial spasm. 61
18617405 2008
819
[Hemifacial spasms and vertebral dolichoectasias]. 61
18985596 2008
820
Lower facial contouring with botulinum toxin type A. 61
19098563 2008
821
The validation of the disease-specific questionnaire for health-related quality of life in Thai patients with hemifacial spasm. 61
19127791 2008
822
Movement disorders in multiple sclerosis: Causal or coincidental association? 61
18768580 2008
823
Endoscopic vascular decompression. 61
18698270 2008
824
Retroclival arachnoid cyst with hemifacial spasm. 61
18946599 2008
825
Hemifacial spasm producing tremor-like movements of the head. 61
18656904 2008
826
[Abnormal muscle response monitoring as a guide during microvascular decompression for hemifacial spasm]. 61
19080452 2008
827
Time course of symptom disappearance after microvascular decompression for hemifacial spasm. 61
19096685 2008
828
Microvascular decompression in hemifacial spasm resulting from a cerebellopontine angle lipoma: case report. 61
18981850 2008
829
Chronologic analysis of symptomatic change following microvascular decompression for hemifacial spasm: value for predicting midterm outcome. 61
18665406 2008
830
Case control MR-CISS and 3D TOF MRA imaging study of medullary compression and hypertension in hemifacial spasm. 61
18709669 2008
831
Abnormal plasticity of sensorimotor circuits extends beyond the affected body part in focal dystonia. 61
17634214 2008
832
[Microvascular decompression for cranial nerve hyperactive dysfunction]. 61
18822736 2008
833
Microvascular decompression for hemifacial spasm: long-term results from 114 operations performed without neurophysiological monitoring. 61
18759569 2008
834
Treatment outcome correlates with knowledge of disease in hemifacial spasm. 61
18583029 2008
835
Microvascular decompression for hemifacial spasm associated with vertebrobasilar artery. 61
19096662 2008
836
Hemifacial spasm in correlation with electrophysiological and radiological findings. 61
19115672 2008
837
Hemifacial spasm associated with an intracranial mass in two dogs. 61
18631227 2008
838
Neurovascular compression findings in hemifacial spasm. 61
18759570 2008
839
[Long-term therapy of focal dystonia and facial hemispasm with botulinum toxin A]. 61
18551268 2008
840
Three-dimensional visualization of neurovascular compression: presurgical use of virtual endoscopy created from magnetic resonance imaging. 61
18728591 2008
841
Tactile temporal discrimination in patients with blepharospasm. 61
17986501 2008
842
Hemifacial spasm. 61
18633924 2008
843
Effectivity of Dysport in patients with blepharospasm and hemifacial spasm who experienced failure with Botox. 61
18751631 2008
844
[Botulinum toxin. Development for therapeutic purposes]. 61
18927957 2008
845
Botulinum toxin type A for refractory post-stroke shoulder pain. 61
18545785 2008
846
Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. 61
18458230 2008
847
[On the occasion of my retirement as head of the Neurochirurgische Universitätsklinik Zürich--changing aspects of treatment modality in modern neurosurgery and of neuroscience research. Presentation of our experience and historical backgrounds]. 61
18516976 2008
848
Efficacy of levetiracetam in hemifacial spasm: a case report. 61
18520988 2008
849
Microvascular decompression of cochlear nerve for tinnitus incapacity: pre-surgical data, surgical analyses and long-term follow-up of 15 patients. 61
17909826 2008
850
Secondary social anxiety in hyperkinesias. 61
18220295 2008
851
The use of botulinum toxin in head and face medicine: an interdisciplinary field. 61
18331633 2008
852
Pain relief in patients receiving periocular botulinum toxin A. 61
18356715 2008
853
Anatomical study of the trigeminal and facial cranial nerves with the aid of 3.0-tesla magnetic resonance imaging. 61
18312095 2008
854
Hemifacial spasm: neurovascular compressive patterns and surgical significance. 61
18297233 2008
855
Vascular Decompression of Trigeminal and Facial Nerves in the Posterior Fossa under Endoscope-Assisted Keyhole Conditions. 61
18769532 2008
856
Differences in improvement between patients with idiopathic versus neurovascular hemifacial spasm after botulinum toxin treatment. 61
18191574 2008
857
Microvascular decompression for hemifacial spasm: analyses of operative complications in 1582 consecutive patients. 61
18261641 2008
858
Chronic isolated hemifacial spasm as a manifestation of epilepsia partialis continua. 61
17951112 2008
859
Use of botulinum toxin A in adult neurological disorders: efficacy, tolerability and safety. 61
18698873 2008
860
[Mechanism of therapy effects by botulinum neurotoxin]. 61
18543757 2008
861
[Disease of lower cranial nerves caused by vascular compression]. 61
18792570 2008
862
The role of genetic factors in the development of hemifacial spasm: preliminary results. 61
18642643 2008
863
Young onset Hemifacial Spasm in patients with Chiari type I malformation. 61
17521950 2008
864
Bilateral hemifacial spasm: a series of 10 patients with literature review. 61
17702626 2008
865
[Neurovascular compression (conflict)]]. 61
18792590 2008
866
Recurrent hemifacial spasm following minor trauma: report of a case. 61
19033709 2008
867
Botulinum toxin in the treatment of blepharospasm and hemifacial spasm. 61
17558461 2008
868
Classification of neurovascular compression in typical hemifacial spasm: three-dimensional visualization of the facial and the vestibulocochlear nerves. 61
18077953 2007
869
Intraoperative three-dimensional visualization in microvascular decompression. 61
18077951 2007
870
[Whole-range encirclement method versus conventional method for microvascular decompression for treatment of hemifacial spasm]. 61
18159014 2007
871
Preservation of the lesser occipital nerve during microvascular decompression for hemifacial spasm. Technical note. 61
18077965 2007
872
Closely spaced stressful life events precede the onset of benign essential blepharospasm and hemifacial spasm. 61
18090560 2007
873
[The utility of presurgical simulation of microvascular decompression by MR virtual endoscopy]. 61
18044226 2007
874
[Hemifacial spasm: over 10 years of treatment with botulinum toxin]. 61
18008262 2007
875
[Hemifacial spasm triggered by dental manipulation]. 61
18021620 2007
876
Hemifacial spasm: a neurosurgical perspective. 61
19096569 2007
877
Poststroke partial seizures presenting as hemifacial spasm. 61
17657813 2007
878
Experiential modification of the trigeminal reflex blink circuit. 61
17898213 2007
879
What is new in the era of focal dystonia treatment? Botulinum injections and more. 61